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 Aquaculture is currently the fastest growing sector of protein production, and is expected to 
overtake the harvest of wild fisheries. Limitations in nutrition, specifically fatty acid nutrition, are 
preventing even more dramatic growth of many species of commercial importance. Currently, much of the 
research involving fatty acids examines requirements as being correlated to thermal guilds (warm vs. cool 
water) or salinity tolerance (marine vs. freshwater). However, recent studies have revealed the potential 
for trophic level to be as much, if not more, influential in determining fatty acid requirements of a species. 
As such, two feeding trials were conducted to determine the requirements of two species of different 
trophic levels (Oreochromis niloticus and Trachinotus carolinus) based on C18 PUFA vs. LC-PUFA. Nile 
Tilapia, O. niloticus, exhibited similar growth regardless of the inclusion of C18 PUFA or LC-PUFA, 
however, tissue fatty acid profiles were influenced per the diet provided. As such, it was concluded that 
Nile Tilapia exhibit the capacity to effectively synthesize LC-PUFA from C18 PUFA as is seen in many 
species that occupy low trophic levels. Florida Pompano, T. carolinus, did not exhibit any significant 
differences in growth regardless of the diet provided, but numerical differences indicated benefits towards 
inclusion of dietary LC-PUFAs. Similar to O. niloticus, tissue fatty acid profiles were significantly affected 
by dietary treatment. Based on numerical differences in growth performance and significant differences in 
tissue fatty acids, it was concluded that Florida Pompano show a typical carnivorous requirement for LC-
PUFA.  
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CHAPTER 1 
INTRODUCTION 
Seafood production is currently 167.2 million metric tons annually and is likely to increase even 
further as the human population is expected to grow by an additional 2 billion people by the year 2050 
(FAO 2014). Rising demand for seafood and the increased industrialization of fishing has created 
enormous harvest pressure, resulting in nearly 90% of all fisheries being classified as fully fished or over 
fished (FAO 2016). Aquaculture, the culture of fish and other aquatic organisms, has grown dramatically 
since the 1990s to close the ‘seafood gap’, i.e., the difference between growing seafood demand and 
relatively static capture fisheries landings.   
Aquaculture production has grown at an average of 8.5% per year over the period of 1950 to 
2006 (Tacon and Metian 2008), making it the fastest growing sector of meat production in the world. Due 
primarily to growth in the aquaculture sector, total annual seafood production (including capture fisheries 
and aquaculture) has nearly tripled, from approximately 40.8 million metric tons in 1970 to 128 million 
metric tons in 2010 (Tacon and Metian 2013). Although capture fisheries landings have been relatively 
static since the 1990s, substantial increases in seafood supply have come from aquaculture, which has 
increased from 1.47 to 38.5 million metric tons of edible seafood from 1970 to 2010 (Tacon and Metian 
2013). In 2014, aquaculture production topped 73 million metric tons (FAO 2016), accounting for 50% of 
the total global seafood supply, an increase from nearly 20% in 1990 (FAO 2014). This growth in the 
aquaculture sector is important to maintain as capture fisheries remain relatively static and the human 
population continues to grow. Due to the human population’s anticipated increase in size, aquaculture is 
expected to continue this trend of increased production and reach 60% of total food fish production by 
2030 (FAO 2014).   
Although continued growth of the aquaculture sector is necessary, it will be constrained by the 
availability of inputs, including cost effective ingredients for aquafeeds. Historically, fish meal and fish oil, 
derived from marine reduction fisheries, were primary sources of protein and lipid in aquafeeds. Fish meal 
is a result of rendering fish tissue (both whole carcass and offal) down into a useable protein-dense 
powder. This powder is then processed further to remove much of the oil contained in the fish meal, 
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creating another product, fish oil. However, like many other capture fisheries, reduction fisheries are 
considered stable, but unlikely to yield substantially greater landings in the future. Simultaneously, 
demand for reduction fishery products has increased with the demand for industrially compounded feeds 
as a result of aquaculture moving away from non-fed, pond, based systems to more intensive culture 
systems dependent on external nutrients (Tacon et al. 2011; FAO 2012). With this increased demand for 
complete feeds, the aquaculture industry’s consumption of available fish meal and fish oil supplies has 
increased. Historically, fish oil was used as a primary lipid source because of its acceptance by aquatic 
species, high energy and long chain polyunsaturated fatty acid (LC-PUFA) content, and competitive 
pricing (Turchini et al. 2009; Tocher 2015). Due to increasing demand, the cost of these products has 
been driven ever higher (FAO 2008; Tacon and Metian 2008), with fish oil surpassing $2,000 USD per 
metric ton in 2013 (FAO 2014). Due to static capture fisheries landings, including reduction fisheries, it is 
anticipated that the cost of fish oil will continue to rise (FAO 2008, 2014; Tacon and Metian 2008). In 
2008, the aquaculture sector consumed 87% of the total fish oil produced for the global market, much of 
which was destined for the production of high value species (Tacon and Metian 2009). Despite decreased 
fish oil inclusion rates in aquafeeds, growth in aquafeed manufacturing is expected to drive fish oil 
demand up by an additional 23 million metric tons (Tacon and Metian 2008; FAO 2012).  
Fish oil is an important source of LC-PUFAs, for which all fishes have a physiological demand. As 
in humans and other vertebrates, LC-PUFAs are needed for reproductive, neurological, vascular, visual 
and other functions in fish (Glencross 2009). Some fish exhibit a dietary requirement for these nutrients 
(i.e., they must consume LC-PUFAs directly), whereas others can meet physiological demand through de 
novo synthesis from ingested 18 carbon polyunsaturated fatty acid (C18 PUFA) precursors. LC-PUFAs are 
a product of metabolic pathways that transform C18 PUFA, namely linoleic acid (LA) and alpha linolenic 
acid (ALA), via the actions of a series of desaturase and elongase enzymes to increase the number of 
carbons and double bonds in the molecule (Sprecher et al. 1995). The production of both n-3 and n-6 LC-
PUFAs is dependent on the same series of enzymes, resulting in inadequate synthesis when substrates 
are limiting or the enzymes are inactive or not present in meaningful amounts (Figure 1.1). A lack of 
enzymes is thought to be caused by a species’ evolutionary adaptation to a diet rich in LC-PUFAs (i.e. 
carnivorous diet), causing a decreased expression of the necessary elongation and desaturation 
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enzymes (Carmona-Antoñanzas et al. 2013; Tocher 2015). Dietary composition is used in determining 
the trophic status of a species, their trophic level. Primary producers being the base of all food webs are 
given a trophic level of 1, primary consumers (herbivores) are given a trophic level of 2, and secondary 
consumers (carnivores) have a trophic level of 3. Carnivores that prey on other carnivores and apex 
predators are assigned to trophic levels of 4 and 5, respectively.  
If a species were to have evolved utilizing a more herbivorous or omnivorous diet largely deficient 
in LC-PUFAs, presumably organisms would need to maintain the ability to produce LC-PUFAs from 
abundant dietary C18 PUFAs (Tocher 2010, 2015; Monroig et al. 2011).  Some of the most globally 
important aquaculture species are thought to have no dietary requreiment for LC-PUFAs; such as carp 
which account for 72% of global freshwater aquaculture production (FAO 2012) and the most widely 
produced species globally, tilapia (FAO 2012). However, there is evidence that total dietary demand for 
fatty acids can be reduced through the inclusion of intact LC-PUFAs in the diet (Tocher 2010). In contrast 
to herbivores and omnivores, most carnivorous fish evolved consuming diets already rich in preformed 
LC-PUFAs.  Consequently, there would be little selective advantage in possessing the ability to 
synthesize these nutrients de novo. Having lost, or never acquired, the ability to produce necessary 
enzymes in meaningful amounts, Red Seabream, Pagrus major (Yone and Fuji 1975; Wantanabe 1982; 
Takeuchi et al. 1992), Yellowtail, Seriola sp. (Furukawa et al. 1966; Tsukuhara et al. 1967; Deshimaru et 
al. 1982) and many other carnivorous species are unable to synthesize LC-PUFAs from C18 PUFAs and 
therefore require intact LC-PUFAs in their diet (NRC 2011). 
The capacity of a fish species to synthesize LC-PUFAs from C18 PUFA precursors largely 
determines whether dietary fish oil sparing (i.e. the replacement of some or all of the fish oil with 
alternative, less expensive, lipid sources) can be effectively achieved. Whereas plant oils (canola, 
coconut, corn, olive, palm, peanut, soybean, etc.) do not offer LC-PUFAs, they typically contain C18 
PUFAs that could be converted into biologically active LC-PUFAs (Figure 1.1) (NRC 2011). In addition to 
the wide variety of plant-based lipids, many of the terrestrial animals produced for human consumption 
have significant amounts of trimmings and waste that can be rendered down to usable sources of lipid; 
these lipid sources include beef tallow, poultry fat, and pork lard (Turchini et al. 2009). Terrestrial animal 
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fats are mainly comprised of mono-unsaturated fatty acids (MUFAs) and saturated fatty acids (SFAs), 
both of which are known to be preferentially catabolized for energy compared to polyunsaturated fatty 
acids (NRC 2011). The utilization of these alternative lipids is a well-established method of reducing the 
inclusion rates of fish oil (Turchini et al. 2009); however, the results of fish oil sparing or complete 
replacement vary among lipid sources and fish species. For example, Gilthead Seabream (Sparus 
aurata) and European Seabass (Dicentrarchus labrax) fed vegetable oil based diets showed no 
significant differences in production performance (Izquierdo et al. 2003), however, Australian Snapper 
(Pagrus auratus) exhibited significantly reduced growth when fed diets of crude or refined canola oil 
(Glencross 2003).  Regarding the species of interest in the present work, see Chapter 2 for information 
regarding the effects of fish oil sparing in Nile Tilapia, Oreochromis niloticus, and Chapter 3 for 
information regarding Florida Pompano, Trachinotus carolinus. Although fish oil sparing has significant 
impacts on the cost of aquafeed production, there are complications associated with it. Due to the 
absence of LC-PUFAs, fish oil sparing can result in fatty acid deficiencies in species unable to synthesize 
LC-PUFAs de novo. Consequently, species lacking the necessary enzymes are particularly prone to 
reductions in growth, feed efficiency, and feed intake as well as tissue fatty acid profiles that are distorted 
when compared to a fish oil fed counterpart (Trushenski et al. 2009, 2012, 2013; Woitel et al. 2014a; 
Bowzer et al. 2016; Emery et al. 2016). However, with the inclusion of LC-PUFAs directly into alternative 
lipid diets or through the use of fish oil-rich finishing feeds at the end of production cycles, it is possible to 
restore much of the production performance and fatty acid profiles to associated with fish oil based diets 
(Trushenski 2012; Bowzer et al. 2016; Emery et al. 2016). 
Knowledge of fatty acid requirements is central to successful sparing or replacement of fish oil in 
aquafeeds, but information regarding the demands for lipids and fatty acids in many commercially 
important species is lacking. Much of the ‘common knowledge’ regarding fatty acid requirements of fish is 
based on the notion that temperature and salinity guilds are the driving causes for different fatty acid 
essentiality, i.e., whether C18 PUFAs or LC-PUFAs are required in the diet. According to these 
conventions, coldwater and marine fish require LC-PUFAs, whereas warmwater and freshwater fish do 
not; however, quantitative investigations have proven that these ‘rules of thumb’ are regularly inaccurate. 
Other studies report “total n-3”, “total n-6”, or merely lipid inclusion rates opposed to individual fatty acids. 
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Fatty acid groupings do offer insight on the requirements of species, however, they do not offer sufficient 
information to develop diets that maximize the production of their respective species. It is very likely that 
due to evolutionary forces, omnivorous species can consume a diet containing C18 PUFAs resulting in 
growth comparable to diets that contain a full suite of LC-PUFAs. On the other hand, it is unlikely that 
retaining or acquiring the ability to synthesize LC-PUFAs would be of considerable selective advantage 
among species consuming food items rich in these nutrients. Fish nutritionists specializing in lipid demand 
and fatty acid requirements increasingly recognize the likely importance of trophic level as a predictor of 
whether a species exhibits a dietary requirement for LC-PUFAs. However, much of the literature and 
associated recommendations continue to focus on the aforementioned temperature/salinity-based 
conventions or ‘requirements’ for fatty acid groupings. The purpose of this thesis was to address the fatty 
acid requirement debate in commercially relevant aquaculture species, assess the essentiality of C18 
PUFA or LC-PUFA in feeds for taxa representing freshwater/marine and omnivore/carnivore dichotomies, 
and facilitate better use of trophic level as predictor of fatty acid requirements of fish.  
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CHAPTER 2 
REEVALUATING ESSENTIAL FATTY ACID REQUIREMENTS OF NILE TILAPIA 
Nile Tilapia inhabit tropical, shallow waterways and are highly adaptable to a wide range of water 
conditions (e.g. temperature, dissolved oxygen, salinity, nitrogenous compounds) (Popma and Masser 
1999). In addition to their tolerance of varied environmental conditions, Nile Tilapia are well-suited to 
aquaculture because they are fecund and reproduce readily in intensive and extensive rearing systems, 
accept a wide variety of feed ingredients, exhibit rapid growth rates, and yield a mildly flavored fillet that is 
desirable to consumers. As a result, tilapias are the most widely cultured aquatic species worldwide (FAO 
2014), with production of Nile Tilapia exceeding 3.6 million metric tons in 2013 (FAO 2017). The 
production of this fish occurs on multiple continents, but many of the producing countries are in Southeast 
Asia. Feed constitutes 45-80% of tilapia farm operational costs, and there is great desire to reduce these 
costs to increase profitability (Ng and Chong 2004).  Protein sources are typically the most costly 
components of aquafeeds, but identification of suitable, low-cost sources of lipids are also needed in 
order to satisfy dietary demands for energy and essential fatty acids.    
The reported essential fatty acid requirements of tilapia are relatively easy to satisfy, and thus 
various lipid sources, including fish oil, plant oils, and terrestrial animal fats, have been used successfully 
in tilapia diets. Utilization of alternative lipid sources has resulted similar or better growth performance 
than fish oil when provided to tilapia (Ng et al. 2001; Mulligan and Trushenski 2013). Red hybrid tilapia, 
Oreochromis sp., fed diets containing cod liver oil grew significantly less efficiently than those fed diets 
containing crude palm oil (Ng et al. 2001). Blue Tilapia, Oreochromis aureus, exhibits a similar capacity 
for utilizing alternative lipid sources: fish fed diets containing menhaden oil, catfish oil, and soybean oil all 
exhibited similar performance, however, beef tallow resulted in reduced growth (Stickney and McGeachin 
1983). The ability to utilize different lipid sources is due to the ability of tilapias to synthesize LC-PUFAs 
from C18 PUFAs (Tocher et al. 2002). Nile Tilapia have a reported dietary requirement for LA (Teshima et 
al. 1982; NRC 2011), but there are indications that direct provision of ARA may be a more efficient means 
of satisfying physiological demand for this n-6 LC-PUFA (Takeuchi et al. 1983). No quantitative 
requirement for n-3 fatty acids has been reported (NRC 2011), but beneficial effects of having both n-3 
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and n-6 fatty acids in the diet of hybrid tilapia have been reported (Chou and Shiau 1999) and there is 
little reason to think that tilapias are unique among vertebrates and that n-3 fatty acids are completely 
dispensable for these taxa. Taken together, these reports suggest that the essential fatty acid 
requirements of tilapia are perhaps not as well-understood as one might expect, given the size of the 
commercial industry.  Although the performance of Nile Tilapia is maintained regardless of the source of 
lipid being used, the fillet tissue fatty acid profile does mimic the profile of the oil being fed (Chou and 
Shiau 1999; Ng et al. 2001; Ng and Chong 2004).  
In order to facilitate fish oil sparing and the flexibility to incorporate a variety of different lipid 
sources in aquafeeds, fish nutritionists and feed manufacturers must know which fatty acids are essential 
and what dietary levels are adequate to satisfy requirements of the intended fish. As such, a more 
accurate understanding of essential fatty acid (EFA) requirements of fish is instrumental to the continued 
growth of global aquaculture. Given the wide variety of species cultured throughout the world, it is 
infeasible to conduct quantitative essential fatty acid requirements in all species. ‘Rules of thumb’ or 
information to help nutritionists predict the dietary requirements of untested species are needed. In the 
past, nutritionists attempted to use species’ preferred water temperatures (warm-, cool-, or coldwater) or 
salinities (freshwater or saltwater) to predict essential fatty acid requirements (e.g., it has been suggested 
that coldwater/saltwater fish require LC-PUFAs, whereas warmwater/freshwater taxa do not), but these 
guidelines have proven inaccurate in many cases. More recently, it has been suggested that trophic level 
may be a better predictor of a fish’s ability to synthesize LC-PUFAs de novo or whether they must 
consume them directly. In order to assess this hypothesis I used Nile Tilapia, a freshwater herbivore 
(trophic level 2.0) (Froese and Pauly 2016), to examine fatty acid requirements on the basis of C18 PUFA 
or LC-PUFA dietary inclusion.   
 
MATERIALS AND METHODS 
PREPARATION AND ANALYSIS OF DIETS 
Seven dietary treatments were formulated based on a previously verified diet (Trushenski et al. 2009; 
Mulligan and Trushenski 2013), including a positive control, negative control, and five experimental 
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treatments amended with C18 PUFA or LC-PUFA ethyl esters (Table 2.1). The positive control ("Fish Oil 
Control”) was formulated to include menhaden fish oil (Virginia Prime Gold™, Omega Protein 
Corporation, Houston, Texas) as the single lipid source. The negative control (“EFA Free Control”) was 
formulated using hydrogenated soybean oil (Dritexs Shortening Flakes, Stratas Foods, LLC, Memphis, 
Tennessee) in place of menhaden oil. Five experimental diets were prepared by amending the EFA Free 
Control formulation with ALA (“ALA”); ALA and LA (“C18 PUFA”); docosohexaenoic acid (“DHA”); DHA 
and arachidonic acid (ARA) (“DHA + ARA”); or ARA, eicosapentaenoic acid (EPA), and DHA (“LC-
PUFA”). All diets were formulated using solvent extracted fish meal to avoid contamination from residual 
fish oil. However, due to residual lipid content present in other ingredients, LA was present in all diets, 
including the EFA Free Control and other experimental diets not supplemented with LA ethyl esters 
(Table 2.2, 2.3). 
 All diets were prepared at the Center for Fisheries, Aquaculture and Aquatic Sciences (CFAAS) 
using established internal practices. Briefly, ingredients were combined using a cutter mixer (Model 
CM450, Hobart Corporation, Troy, Ohio) and then pelleted using a commercial feed grinder (1.5 h.p. 
grinder, Cabela’s, Sydney, Nebraska). After pelleting, the feeds were dried at 100°C in a commercial 
dehydrator (Harvest Saver R-5A, Commercial Dehydrator Systems, Eugene, Oregon). All diets were 
stored frozen (-20°C) throughout the duration of the trials, prior to commencement of the trial triplicate 
samples of each diet were collected and lyophilized (Freezone6, Labconco, Kansas City, Missouri) for the 
determination of moisture content. The samples were then pulverized for further analysis of ash, protein, 
and lipid content. Ash content of all diets was determined using a muffle furnace set to 650°C for 4 hours 
and allowed to cool overnight. Protein content was determined using a combustion method of nitrogen 
determination (LECO® FP-528, LECO Corporation, St. Joseph, Michigan). Lipid content was determined 
gravimetrically via chloroform/methanol extraction (Folch et al. 1957), followed by acid transmethylation 
for fatty acid determination (Christie 1982). Quantification of FAMEs was achieved via gas chromatograph 
equipped with a flame ionization detector (GC-FID) (GC-17A, Shimadzu Kyoto, Japan) fitted with a fused 
silica capillary column (30m x 0.25mm interior diameter) (Omegawax 250, Supelco, Bellefonte, 
Pennsylvania). Fatty acid methyl esters were identified by comparison to external standards (Supelco 37 
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FAME component, PUFA-1, PUFA-3, DHA, ARA, Supelco, Bellefonte, Pennsylvania; 20:3n-9, 22:5n-6, 
Cayman Chemical Company, Ann Arbor, Michigan). 
EXPERIMENTAL DESIGN 
Juvenile phenotypically male (sex-reversed) Nile Tilapia were sourced from Americulture, Inc. 
(Animas, New Mexico) at approximately 0.5 g/fish. A recirculating system consisting of 28, 150 L 
fiberglass aquaria and associated mechanical and biological filtration at the CFAAS was stocked with 10 
randomly selected fish (25.7 ± 0.2 g/fish; mean ± SE). Prior to commencement of the trial all fish were 
raised on a commercially available diet. All diets were randomly assigned to quadruplicate tanks (N=4) for 
each trial, with each tank being fed to satiation twice daily for 7 weeks. Temperature and dissolved 
oxygen were monitored daily using a Hach HQ40d meter (Hach; Loveland, Colorado), monitoring of 
ammonia, nitrite, nitrate and alkalinity was conducted via spectrophotometric analysis (Hach; Loveland, 
Colorado). Water quality parameters were maintained within ranges suitable for Nile Tilapia rearing: 
temperature = 27.7 ± 0.7℃; dissolved oxygen = 5.5 ± 0.6 mg/L; total ammonia = 0.03 ± 0.02 mg/L; nitrite 
= 0.05 ± 0.03 mg/L; nitrate = 39.0 ± 9.9 mg/L; alkalinity = 110.3 ± 43.8 mg/L (mean ± SD).  
SAMPLE COLLECTION AND ANALYSIS 
At the conclusion of the trial, all fish from each tank were euthanized using an overdose of 
tricaine methanesulfonate (MS-222; >200 mg/L until cessation of opercular movements for ~ 5 min) 
(Figure 2.1). Individual fish were weighed and measured (total length), and 5 fish were randomly selected 
for tissue collection and stored frozen (-20°C) until dissection. Production performance metrics were 
calculated as follows:  
Weight Gain (%)  =  100 × 
(average final individual weight −  average initial individual weight)
average initial individual weight
 
Feed Intake (% body weight d⁄ ) = 
100 × 
average individual dry matter feed intake
(average initial individual weight × average final individual weight)
0.5
days of feeding
⁄
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Specific Growth Rate (SGR, % body weight/d) = 100 × 
log
e
average final weight - log
e
average initial weight
days of feeding
 
Feed Conversion Ratio (FCR) = 
average individual dry matter feed intake 
average individual weight gain
 
HSI = 100 × ( liver weight  whole body weight)⁄  
VSI = 100 × (viscera weight / whole body weight) 
Samples of liver, white muscle, intraperitoneal fat (IP fat), brain, and eye tissues were collected 
from each fish dissected and stored frozen (-80℃) until fatty acid analysis. Muscle samples were 
lyophilized and pulverized in the same manner described above for diet samples, and then subjected to 
chloroform/methanol lipid extraction (Folch 1957). All other tissues were homogenized directly in solvent 
(PowerGen 1000 homogenizer; Fisher Scientific, Pittsburgh, PA) without lyophilization prior to lipid 
extraction. Resulting total lipid fractions were then subjected to transmethylation and FAME quantification 
as described above.   
Essential fatty acid deficiency indicator ratios were calculated for all tissues, including 20:3n-9 : 
20:4n-6 and 22:5n-6 : 22:6n-3. These ratios have been implicated in assessing the relative deficiencies 
that can arise when EFA are not provided in appropriate amounts (Galli et al. 1974; Siguel et al. 1987). 
Long-chain PUFA are formed using the same series of enzymes, resulting in the formation of fatty acids 
that are of lower biological value. Identification of an ARA deficiency is accomplished by comparing the 
values of 20:4n-6 and 20:3n-9, both of which utilize Δ5 desaturase. The formation of 22:5n-6 and 22:6n-3 
utilizes the Δ6 desaturase, with an increased ratio value indicating a deficient diet. By comparing the 
relative amounts of these fatty acids, deficient diets could be identified prior to physical symptoms arising.  
Coefficient of Distance (Djh) values (Turchini et al. 2006), comparing differences in tissue fatty 
acid profiles between all treatments and the Fish Oil Control diet, were calculated as follows:   
Djh= [∑(Pij-Pih)2
n
i=1
]
1 2⁄
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Where Pij represents the percent of fatty acid “i” present in the positive control treatment and Pih represents 
the percent of fatty acid “i” present in an experimental treatment. Only major fatty acids (>1% of total 
quantified FAME; no fatty acid groupings e.g. SFAs, MUFAs) were included in the calculation of Djh. Based 
on these calculations, a smaller Djh value represents tissue profile similarity between treatments, and a 
value of zero indicates identical tissue profiles. 
STATISTICAL ANALYSIS 
One-way ANOVA procedures were used to analyze all production performance metrics, and fatty 
acid data (PROC GLIMMIX; SAS version 9.4, SAS Institute, Cary, North Carolina) with tanks serving as 
experimental units (N=4). When omnibus tests indicated significant treatment effects, post-hoc Tukey’s 
HSD tests were used for pairwise comparisons of treatment means. In all cases, effects and differences 
were considered significantly different at critical values less than or equal to 0.05. Coefficient of distance 
values were not subjected to formal statistical analysis because of insufficient numbers of replicates (Djh 
was calculated from fatty acid means, resulting in a single value for each tissue within a treatment). 
 
RESULTS 
 Although survival did not vary among treatment groups (98-100%), dietary lipid source and fatty 
acid composition significantly affected other aspects of production performance (Table 2.4). Weight gain, 
FCR and SGR were significantly greater among fish fed the Fish Oil Control feed in comparison with 
those fed the EFA Free Control feed.  The addition of fatty acid ethyl esters generally improved 
performance in most cases:  growth was sufficiently enhanced to achieve equivalence with the Fish Oil 
Control treatment group in all experimental groups except DHA and ARA + DHA, but FCR was only 
significantly improved among fish fed the C18 PUFA diet. Feed intake, hepatosomatic index (HSI), and 
viscerosomatic index (VSI) did not vary among treatments. 
 Fatty acid composition of tissues varied significantly among treatments, generally reflecting 
dietary fatty acid profile (see Table 2.2 for dietary fatty acid composition, and Tables 2.5 – 2.9 for tissue 
fatty acid composition). Levels of SFAs were elevated in all experimental diets relative to the Fish Oil 
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control, however, these fatty acids were not proportionately incorporated into all tissues. Other fatty acids 
including ALA, LA, ARA, DHA, and EPA were more consistently reflected in tissues when incorporated 
into the dietary treatments. Increased levels of ARA were observed in all experimental treatments across 
multiple tissues (i.e. fillet, liver, brain, and eye) (Tables 2.5, 2.6, 2.7, 2.8, 2.9). Brain tissue with depressed 
levels of DHA was noted in fish receiving the C18 PUFA diet compared to all other diets (Table 2.8). 
Intraperitoneal fat (Table 2.7) exhibited similar patterns as seen in fillet tissue, except for a significant 
increase in ARA. Brain (Table 2.8) tissue exhibited similar trends as other tissues in regards to reflecting 
the dietary consumption, but with much less distortion than all other tissues (Table 2.10).   
In all tissues, with the exception of IP fat, the highest values for 20:3n-9 : 20:4n-6 were observed 
in the DHA treatment, followed by treatments not provided with n-6 fatty acids (i.e. ALA, C18 PUFA, and 
EFA-Free Control). However, in the IP fat samples, the highest values of this ratio were present in the 
treatments containing LC-PUFAs (i.e. DHA, ARA+DHA, and LC-PUFA) as well as the EFA-Free Control. 
The ratio between 22:5n-6 and 22:6n-3 in treatment groups provided with diets having a ratio of n-3 to n-6 
greater than 1.2 was consistently lower across all tissues compared to treatment groups provided diets 
with a greater proportion of n-6 fatty acids.   
 
DISCUSSION 
 Provision of intact LC-PUFA to juvenile Nile Tilapia resulted in no significant effect on growth 
compared to diets containing C18 PUFA. The ability to grow and develop properly when provided diets 
lacking LC-PUFA has been reported previously in trials with tilapia (Teshima 1982; Chou and Shiau 1999; 
Trushenski et al. 2009). Based on the numerical differences in my trial, there is evidence supporting the 
current fatty acid recommendations (NRC 2011) for Nile Tilapia requirement of LA. Although the EFA-
Free control contained more LA than the reported requirement (NRC 2011), both the ALA and C18 PUFA 
diets performed better. The growth benefit associated with the combination of both n-3 and n-6 fatty acids 
has been implied previously in hybrid tilapia (O. niloticus x. O. aureus) (Chou and Shiau 1999). 
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 Reflection of dietary fatty acid intake in tissues has been reported in numerous species (Craig 
and Gatlin 1995; Chou and Shiau 1999; Trushenski et al. 2013; Bowzer et al. 2016). The present study 
indicates that Nile Tilapia might benefit from both dietary n-3 and n-6 fatty acids as first suggested by 
Chou and Shiau (1999). Tissues most affected by the alteration of dietary fatty acids were those reported 
by others to be the most compositionally plastic (i.e. fillet, liver, intraperitoneal fat, and, to a lesser extent, 
eye tissue); brain tissue profiles were the least distorted as a result of dietary manipulation. However, 
comparing ALA and C18 PUFA treatments indicated a lower distortion of all tissues in fish fed a diet rich in 
ALA (Table 2.10). This is further evidenced by the DHA and LC-PUFA diets having the least tissue 
distortion among all diets. 
Among fish fed the EFA Free Control feed, in which LA was the only PUFA present in appreciable 
amounts, there was a significantly higher level of ARA present in muscle tissue; however, this level 
dropped in the presence of ALA in the diet (ALA and C18 PUFA), as well as in diets containing DHA. The 
provision of intact n-3 LC-PUFA (namely EPA and DHA) has been implicated in the down regulation of 
many enzymes responsible for LC-PUFA biosynthesis (Clarke 2001). Thus, it is possible that increased 
availability of DHA in excess of physiological demand among fish fed the DHA-supplemented feeds 
induced a down-regulation of Δ6 Fad, indirectly resulting in less ARA synthesis and deposition (Chou et 
al. 1999). In the case of the ALA and C18 PUFA diets, the presence of a competing substrate, i.e., ALA, 
may have effectively reduced ARA synthesis from LA.  
 When provided with n-3 fatty acids (ALA and DHA), tissue 20:3n-9/20:4n-6 ratios declined in Nile 
Tilapia. Synthesis of 20:3n-9 typically occurs in the absence of biologically active 20-carbon PUFA, but 
the organism is unable to synthesize the needed fatty acids. The use of the Δ5 desaturase enzyme 
complex is required for the proper desaturation of both 20:4n-3 and 20:3n-6 to 20:5n-3 (EPA) and 20:4n-6 
(ARA), respectfully (Figure 1.1). Once the physiological demand for EPA, or more specifically DHA, was 
met in treatments amended with either ALA or DHA, the conversion of all precursors was dramatically 
reduced. Thus, an increase in 20:3n-9/20:4n-6 ratio indicates a developing or ongoing essential fatty acid 
deficiency (namely LA). The results of this study appear to indicate that in a diet containing mainly LA 
(EFA-Free control; Table 2.3) Nile Tilapia produce significantly more 20:3n-9 than when provided with 
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ALA and LA simultaneously. This finding, coupled with the growth performance results I observed 
suggests that Nile Tilapia do indeed have a dietary requirement for n-3 PUFAs, but that this requirement 
can be met through provision of ALA and that dietary provision of n-3 LC-PUFA is not explicitly 
necessary. These results are consistent with the understanding that fatty acids are synthesized in an n-3 
> n-6 > n-9 fashion (Tocher 2010). Although significant differences in both fatty acid deficiency indicator 
ratios (20:3n-9 : 20:4n-6, and 22:5n-6 : 22:6n-3) in all tissues were present, no fish showed any gross 
indications of fatty acid deficiency. Fish fed diets amended with high levels of n-3 fatty acids (i.e. ALA, 
DHA, and LC-PUFA) consistently experienced higher ratios of 20:3n-9 to 20:4n-6, as well as lower levels 
of 22:5n-6 to 22:6n-3. Alternatively, treatments with high levels of n-6 fatty acids (i.e. EFA-FREE, C18 
PUFA, and ARA) exhibited low levels of 20:3n-9/20:4n-6 and high levels of 22:5n-6/22:6n-3. Typically, a 
20:3n-9/20:4n-6 ratio of >0.2 is considered indicative of a fatty acid deficiency in mammals, however, it is 
not until the ratio surpasses 0.4 that clinical signs are exhibited (Holman 1971a, 1971b, 1978). Using a 
20:3n-9/20:4n-6 ratio value of >0.2 no experimental treatments experienced acute fatty acid deficiency in 
fillet tissues, however, intraperitoneal fat from all diets containing LC-PUFA (i.e. DHA, ARA+DHA, and 
LC-PUFA) all exhibited ratio values of >0.9. As IP fat is understood to act as storage for excess lipid, and 
subsequently fatty acids, this tissue might not be the most informative when determining essential fatty 
acid deficiency (EFAD). Although no value for determining a fatty acid deficiency with a 22:5n-5/22:6n-3 
ratio, it has been suggested that higher levels indicate declining health (Galli et al. 1974). Based on my 
results there are clear indications that in treatments provided with n-3 fatty acids the values of 22:5n-
6/22:6n-3 are much lower than in treatments provided with n-6 fatty acids.  
 As a species with a low trophic classification, Nile Tilapia (trophic level = 2.0 (Froese and Pauly 
2016) are one of the most widely produced species globally (FAO 2014). Low trophic level species, 
including Nile Tilapia, Common Carp (trophic level 3.0) (Froese and Pauly 2016) and catfish (including 
Pangasius, trophic levels = 3.1 - 3.4) (Froese and Pauly 2016) are expected to account for approximately 
60% of global aquaculture production by 2025 (FAO 2016). Common carp, a cool, freshwater species 
(trophic level = 3.0) (Froese and Pauly 2016) is reported as having a dietary requirement for both ALA 
and LA (Takeuchi and Wantanabe 1977). Grass carp (trophic level = 2.0) (Froese and Pauly 2016) are a 
warm, freshwater species reported to have a similar requirement of both ALA and LA (Takeuchi et al. 
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1991). Ayu (Plecoglossus altivelus) is a coolwater, catadromous species (trophic level = 3.0) (Froese and 
Pauly 2016) with reported fatty acid requirements of ALA (Kanazawa et al. 1982). Combined with the 
results of my trial, there appears to be a trend indicating that fish species adapted to low trophic levels, 
regardless of thermal or salinity preference, can utilize dietary C18 PUFA to produce and satisfy 
physiological demand for derivative LC-PUFAs. This trend can be a useful start when determining a 
potential aquaculture species’ fatty acid requirements.  
Further research is needed to determine if the numerical differences shown in this trial were 
indeed non-significant, or if given a longer period of time significant differences would develop. Although 
sufficient statistical power was present, a longer trial length would allow for additional growth and further 
separation of treatment effects. As hypothesized, Nile Tilapia appear to have a dietary requirement for C18 
PUFA likely due to their low trophic level. Additional trials are required to determine the specific levels that 
are required for the optimal growth of juvenile Nile Tilapia, followed by advanced stages of growth and 
eventually reproduction as these stages will likely have different fatty acid requirements.  Additional 
studies of species with different trophic levels will provide additional information regarding the use of 
trophic level as an indicator of fatty acid requirements.  
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CHAPTER 3 
EVALUATION OF ESSENTIAL FATTY ACID DEMANDS OF FLORIDA POMPANO 
Florida Pompano, Trachinotus carolinus, is a tropical, marine carnivorous fish. Florida Pompano 
are a coastal, shallow water, pelagic species that are commonly found in schools near beaches, as well 
as in bays and estuaries (Main et al. 2007). Interest in Florida Pompano culture has been driven by the 
species’ tolerance for varied dissolved oxygen and salinity levels, iteroparity and ability to spawn 
throughout the year, and rapid growth (Main et al. 2007; Riley and Weirich 2010), as well as the 
popularity of pompano fillets due to their light flavor and flaky texture (Main et al. 2007).  High demand 
coupled with limited supply has led to retail prices of Florida Pompano ranging between $20.00 and 
$31.11 per kg in 2014 (FAO 2017). Despite the high prices and demand for Florida Pompano, currently 
there is limited commercial fishing or aquaculture production (Main et al. 2007). Currently, the 
considerable potential of Florida Pompano culture is constrained by the comparatively limited information 
available to support optimization of husbandry practices, including nutrition and feeding.  Quantitative 
nutrient requirements are generally lacking and recommendations regarding feed selection and feeding 
practices are general and largely adapted from information available for other species.   
Much of the information regarding Florida Pompano has focused on bulk lipid demand, with very 
limited information regarding fatty acid requirements. However, the information available suggests that 
fish oil, or rather the LC-PUFAs fish oil provides, are especially important in Florida Pompano feeds.  For 
example, growth of juvenile Florida Pompano was directly related to dietary inclusion rate of fish oil, with 
a range of 234 – 826% weight gain when fed 0, 4, 8, or 12% fish oil (Williams et al. 1985). The addition of 
8% fish oil resulted in the highest weight gain (826%) as well as the most efficient FCR of 1.86 (Williams 
et al. 1985). The addition of fish oil, in addition to enhancing growth, resulted in significantly higher 
survival and the prevention of growth abnormalities including lesions of gills and operculum (Williams et 
al. 1985), suggesting that essential fatty acid levels were the limiting factor in the other, lower fish oil 
inclusion diets. These authors cited the presence of LC-PUFAs present in fish oil, specifically EPA and 
DHA, and attributed the differential performance they observed to the relative abundance of these 
nutrients in Florida Pompano diets.  
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Although the work of Williams et al. (1985) is suggestive, it does not definitively prove that LC-
PUFAs are required nutrients in Florida Pompano feeds as there is evidence that Pompano are capable 
of utilizing alternative lipid sources not containing LC-PUFAs. It was recently shown that the replacement 
of 75% of dietary fish oil can be successful with multiple plant based oils (Rombenso et al. 2016a). In 
these trials, juvenile fish were successfully raised for 8 weeks on alternative lipids with no significant 
differences in weight gain and, although significant, only small differences in feed conversion ratios. 
However, Pompano do show a trend (Rombenso et al. 2016a) similar to other marine species (Trushenski 
et al. 2011, 2012, 2013; Woitel et al. 2014a, 2014b) of altered fillet fatty acid composition according to the 
fatty acids provided in the diet. The capacity for fish oil sparing in this species is further supported by the 
complete replacement of fish oil with beef tallow (Rombenso et al. 2016b). This study also implied greater 
importance of DHA over EPA in the growth of Pompano, a result that has been identified in several 
species of carnivorous species (Trushenski et al. 2012; Bowzer et al. 2016, Emery et al. 2016).  
The limited information available appears to indicate that Florida Pompano, like many other 
marine carnivores, exhibit a dietary requirement for LC-PUFAs.  All vertebrate animals exhibit 
physiological demand for ARA, EPA, and DHA, but many are able to meet this physiological demand 
through de novo synthesis of LC-PUFAs from C18 PUFA precursors, i.e., LA and ALA.  For these 
species, including various herbivorous or omnivorous fishes (Benitez and Gorriceta 1985; Radunz-Neto et 
al. 1996; Xu and Kestemont 2002; Lim et al. 2011; Morais et al. 2012), a diet with adequate levels of LA 
and ALA is sufficient to support growth and survival.  For other species, including many marine carnivores 
and possibly Florida Pompano, such biosynthetic transformations cannot be completed at a rate sufficient 
to meet physiological demand for LC-PUFAs.  As such, they must be provided with these nutrients in the 
diet to ensure survival and normal growth and development.  Knowing whether C18 PUFAs and/or LC-
PUFAs are required in the diet of Florida Pompano is central to proper dietary formulation and least-cost 
feeding of this species.  Accordingly, I evaluated fatty acid requirements of Florida Pompano fed diets 
containing C18 PUFAs or LC-PUFAs.  
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METHODS 
PREPARATION AND ANALYSIS OF DIETS 
Seven dietary treatments generally consistent with diets used in previous Florida Pompano 
research were formulated in the same manner as described in Chapter 2. Preparation of diets was 
conducted the same as described in Chapter 2, as was determination of proximate and fatty acid 
composition (Table 3.2). 
 
EXPERIMENTAL DESIGN 
Juvenile Florida Pompano were obtained from ProAquatix (Vero Beach, FL) and raised on a 
commercial diet until of an appropriate size able to consume the experimental diets. A recirculating 
system consisting of 24 (of which 21 were used), 300 L fiberglass aquaria and associated mechanical 
and biological filtration at the Virginia Seafood Agricultural Research and Extension Center (VSAREC) 
was stocked with 8 randomly selected fish (47.4 ± 0.6 g/fish; mean ± SE). All diets were randomly 
assigned to triplicate tanks (N=3), with each tank being fed a fixed ration (4% of body weight) split 
between two daily feedings for 7 weeks; fish were weighed every two weeks to adjust feeding rates for 
growth. Temperature and dissolved oxygen was monitored daily using a YSI 550 meter (YSI, Inc.; Yellow 
Springs, Ohio), monitoring of ammonia, nitrite, nitrate and alkalinity was conducted via 
spectrophotometric analysis (Hach; Loveland, Colorado). Water quality parameters were maintained 
within ranges suitable for Florida Pompano (Pfeiffer and Riche 2011) rearing: temperature = 27.3 ± 0.3°C; 
dissolved oxygen = 6.9 ± 0.4 mg/L; total ammonia = 0.50 ± 0.87 mg/L; nitrite = 0.13 ± 0.12 mg/L; nitrate = 
17.26 ± 9.58 mg/L; alkalinity = 148.9 ± 18.4 mg/L; salinity = 22.5 ± 0.9 ppt. 
 
SAMPLE COLLECTION AND ANALYSIS 
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At the conclusion of the trial, group weights were recorded from each tank, with 5 fish from each 
tank were euthanized using an overdose of tricaine methanesulfonate (MS-222; >200 mg/L) (Figure 2.1). 
Euthanized fish were then frozen at -10°C overnight, followed by -80°C for three days, after which they 
were packed with dry ice and shipped to the CFAAS overnight. Upon arrival at the CFAAS, weights and 
lengths were recorded and all tissues for analysis were collected. All other methods of tissue collection 
and analysis were performed in the same manner as Chapter 2, with the exception that only 3 samples 
from each tank were used in the tissue analysis.  
 
RESULTS 
 Although no significant differences in production performance (i.e. weight gain, FCR, SGR, and 
FI) existed between the EFA-Free control and experimental diets, there were significant differences 
between the Fish-Oil Control and all other treatments (Table 3.4). Significant differences in HSI were 
observed between the ALA diet and the ARA+DHA and LC-PUFA diets.  Although no statistical 
differences were noted among experimental diets, there were numerical trends indicating benefits when 
including intact LC-PUFA (specifically ARA and DHA). 
 Fatty acid composition varied significantly between all tissues, generally reflecting dietary fatty 
acid profiles (see Table 3.2 for dietary fatty acid composition, and Tables 3.5 – 3.9 for tissue 
composition). Levels of SFAs were elevated in all experimental diets relative to the Fish Oil Control, 
however, these fatty acids were only slightly different among fillet tissues. Alternatively, levels of MUFAs 
were reduced in all experimental diets relative to the Fish Oil Control, but these fatty acids were generally 
elevated in fillet tissues of experimental treatments. Fillet tissues all exhibited higher levels of LC-PUFA 
compared to C18 PUFA when provided in the diet (i.e. Fish Oil Control, DHA, ARA+DHA, and LC-PUFA 
diets) (Table 3.5). There were no detectable levels of 20:3n-9 in any liver samples, and very low levels in 
the other tissues sampled, with many of the dietary treatments showing no detectable levels. Levels of 
22:5n-6 were noted in all dietary treatments, with significantly higher levels of 22:5n-6 : 22:6n-3 in fish fed 
the ARA+DHA diet compared to all other treatment groups.  
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 Dietary treatment affected the fatty acid profile of all tissues, but the degree to which fatty acid 
profile was affected differed among tissues (Tables 3.5 – 3.9). However, as the LC-PUFA content of the 
diets increased there was a reduction in the total tissue distortion, as shown by the coefficient of distance 
values (Table 3.9). The coefficient of distance values were largest among fish fed the negative control 
(EFA Free Control) as well as ALA and C18 PUFA diets.  However, there was a dramatic decrease when 
DHA was added, with additional decreases in distance from the reference treatment when ARA, or ARA 
and EPA were added to the DHA. The only tissue that showed to have minimal distortion from dietary 
treatment was the brain, with a maximum distortion of only 4.0 (EFA-Free control) and a minimum 
distortion of 2.0 (DHA). 
 
DISCUSSION 
 Reflection of dietary fatty acids is a well-documented phenomenon (Sargent et al. 1989, 2002; 
Bell 1998) shown to exist in a variety of fish species. In the current study, levels of fatty acids present in 
tissues were significantly affected by dietary treatments. Most notably, significant increases in LC-PUFA 
content were present when fish were provided with dietary ARA, DHA, and EPA. Equivalent increases in 
tissue levels of LC-PUFAs were not associated with increasing dietary provision of LA and/or ALA, 
suggesting limited elongation/desaturation activity.  Rombenso et al. (2016a) reported similar fatty acid 
results in Florida Pompano, with reduced levels of LC-PUFA despite the presence of the respective 18 
carbon precursors. European Seabass exhibited reduced levels of LC-PUFA when fed diets containing 
vegetable oil as a replacement for fish oil (Mourente et al. 2006). Fatty acid content of Cobia fillet tissue 
has been shown to be negatively affected when a diet deficient in LC-PUFA is provided (Trushenski et al. 
2011, 2012). In both trials a reduction of dietary LC-PUFA was connected with reduced levels of the 
respective fatty acids in tissues. The trend of decreased LC-PUFA content in tissues indicates an inability 
to transform the 18-carbon precursors (ALA and LA) to their respective LC-PUFA (DHA, EPA, and ARA, 
respectively).  
The lack of 20:3n-9, and subsequently the ratio of 20:3n-9:20:4n-6, appears to further 
substantiate the claim of Florida Pompano’s inability to elongate and desaturate C18 PUFA to LC-PUFA. 
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Formation of 20:3n-9 requires Δ5 desaturation (Tocher 2010), the same process that is required in the 
formation of EPA and ARA in their formation from ALA and LA, respectively. The formation of 20:3n-9 
from 18:1n-9 has been shown in previous studies to occur when a limiting amount of LA is provided to 
both mice and rats (Allmann and Gibson 1965; Ling et al. 2012). Although the diets all contained a low 
level of LA, fish exhibited no capacity to produce ARA or 20:3n-9 from their respective C18 PUFA.  
Although successful elongation and desaturation of C18 PUFA would also result in very low levels of 
20:3n-9, limited availability of 18:1n-9 in all diets may have constrained any limited amount of synthesis 
occurring.  Combining the lack of 20:3n-9 with the low levels of ARA in all diets lacking supplementation 
indicate that Florida Pompano are unable to properly form LC-PUFA do novo. If the capacity to form LC-
PUFA was present, fish fed diets containing LA or ALA would be expected to exhibit tissue LC-PUFA 
levels higher than those fed the EFA Free (-) Control, if not similar to those fed diets containing intact LC-
PUFA.  Provision of LA and/or ALA did not appear to result in significant increases in tissue levels of 
ARA, EPA, or DHA (particularly in liver tissues, the primary site of LC-PUFA biosynthesis) as observed in 
Nile Tilapia (Chapter 2), suggesting that de novo synthesis was absent or limited in Florida Pompano.   
In contrast to 20:3n-9, the presence of 22:5n-6 was noted in all tissues. The formation of 22:5n-6 
utilizes Δ6 desaturation after the formation of ARA, similar to how EPA is used in the formation of DHA. If 
EPA is limiting, DHA synthesis will be reduced and transformation of the next preferred substrate for Δ6 
desaturase, namely ARA, will increase. Neuringer et al. (1986) provided pregnant rhesus monkeys, and 
their offspring, with diets deficient in both DHA and ALA. In all offspring provided with a deficient diet, a 
significant increase in 22:5n-6 was reported across brain and retinal tissue. Even though no level of 
22:5n-6 was specified as indicating deficiency, the offspring with elevated 22:5n-6 levels did exhibit poorly 
developed neural and ocular systems. Although my trial resulted in significant differences in levels of 
22:5n-6, no differences in behavior or survival were noted. The absence of these gross indicators of EFA 
deficiencies indicates that the fish had not reached the critical threshold for developmental inhibition.  A 
longer trial might have yielded greater evidence of deficiency, including gross pathology or mortality.    
Florida Pompano, a marine carnivore (trophic level 3.5) (Froese and Pauly 2016), do not have a 
defined fatty acid requirement. Based on the results of my trial, there are indications that Florida 
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Pompano lack that ability to properly synthesize LC-PUFA from C18 PUFA. When provided with diets 
containing intact LC-PUFA, there was numerically superior growth and tissue fatty acid compositions that 
were more closely similar to the Fish Oil Control. The provision of dietary LC-PUFA has been shown to 
restore growth performance and tissue fatty acid composition in other carnivorous species including: 
European Seabass (Dicentrarchus labrax), Cobia (Rachycentron canadum), and Red Drum (Sciaenops 
ocellatus) (Craig and Gatlin 1995; Mourente et al. 2006; Trushenski et al. 2011, 2012). Although there 
was similarity between diets containing LC-PUFA and the positive Fish Oil Control, the levels of LC-PUFA 
available in the experimental diets were different than that available in the positive control (Table 3.3). 
The amount of ARA in both ARA+DHA and LC-PUFA diets was more than 4 times that provided by the 
Fish Oil Control, however, the levels of both EPA and DHA were less than one half of that of the positive 
control. Although there is no established EFA requirement for Florida Pompano, my study indicates that 
the levels of fatty acids (Table 3.3) provided are sufficient for various species of fish with established EFA 
requirements. Tocher (2010) assembled a variety of fish species of different salinity and temperature 
tolerances, with many of the marine species displaying EFA requirements of 0.3 – 5.5 % of the dry diet. 
Results from my trial indicate that Florida Pompano have superior performance when provided with at 
least 5.5 g fatty acid/kg of diet (0.55% dry diet) or when provided with 9.9 g fatty acid/kg of diet 
(approximately 1.0% dry diet) of ARA and DHA combined. These results are similar to that reported for 
European Seabass (Dicentrarchus labrax; trophic level 3.47) (Froese and Pauly 2016) which has a 
reported EFA requirement of 1.0 % [dry diet] n-3 LC-PUFA (NRC 2011). Other carnivorous species 
exhibit similar dietary requirements for LC-PUFA including: Atlantic Salmon (Salmo salar; trophic level = 
3.76) (Froese and Pauly 2016), Gilthead Sea Bream (Sparus aurata; trophic level = 3.4) (Froese and 
Pauly 2016), Red Sea Bream (Pagrus major; trophic level = 3.7) (Froese and Pauly 2016), Striped Jack 
(Pseudocaranx dentex; trophic level = 3.66) (Froese and Pauly 2016), and Yellowtail (Seriola 
quinqueradiata; trophic level = 3.96) (Froese and Pauly 2016). Cumulatively, these species combined 
with the results of my trial indicate that species of a higher trophic level, regardless of salinity of thermal 
preference, require dietary LC-PUFA in order to meet their physiological demands. This information can 
be useful in the determination of a potential aquaculture species’ fatty acid requirements. 
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Although non-significant, numerical differences between dietary treatments indicate better 
performance, which, combined with tissue fatty acid composition provide evidence for an LC-PUFA 
requirement for Florida Pompano. This conclusion supports my hypothesis that Florida Pompano are 
similar to other carnivorous species in their dietary requirement for LC-PUFAs. If my trial was conducted 
for a longer period of time these numerical differences might have developed into significant differences. 
Additional trials are required to determine specific values that juvenile Florida Pompano require for 
optimal growth and fatty acid composition, followed by advanced stages of growth and reproductive 
status. Future studies with other carnivorous species will provide additional information as to the use of 
trophic level as a successful indicator of fatty acid requirements.  
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CHAPTER 4 
RECOMMENDATIONS FOR DIETARY FATTY ACID INCLUSION BASED ON TROPHIC LEVEL 
 Nile Tilapia exhibited the ability to utilize C18 PUFA in the proper formation of LC-PUFA (i.e., 
tissue profiles suggest that some of the ALA and LA provided in the LC-PUFA-free experimental diets 
was transformed into their n-3 and n-6 LC-PUFA derivatives), and no evidence of essential fatty acid 
deficiency was observed in fish provided diets containing LA and ALA. The successful use of C18 PUFA-
rich ingredients in diets for Nile Tilapia has been shown previously (Chou and Shiau 1996; Teshima 1982; 
Trushenski et al. 2009; Mulligan and Trushenski 2013), and is not surprising as it occupies a low trophic 
level (2.1) (Froese and Pauly 2016). The natural diet of Nile Tilapia consists largely of detritus and plant 
material, both of which are likely to contain large amounts of C18 PUFA rather than LC-PUFA. As LC-
PUFA biosynthesis is energetically costly, it was hypothesized that dietary inclusion of LC-PUFA would 
result in more efficient growth. Tissue levels of ARA, DHA and EPA were significantly higher in most 
tissues when these LC-PUFAs were supplemented directly in the diet, but growth was not significantly 
enhanced.  Indeed, the fatty acid deficiency indicator ratios (20:3n-9/20:4n-6 and 22:5n-6/22:6n-3) 
suggested that direct provision of n-3 LC-PUFA might inhibit synthesis of n-6 LC-PUFA: a high 20:3n-
9/20:4n-6 ratio in the DHA treatment raises concern regarding the possibility of a developing ARA 
deficiency.  It has been established in other species that dietary provision of LC-PUFA results in 
suppression of elongase and/or desaturase activity (Clarke 2001; Ling et al. 2012) in those species 
capable of de novo LC-PUFA synthesis. Given that the same enzymes are involved in synthesis of both 
n-3 and n-6 LC-PUFA, it is possible that excessive dietary supplementation with DHA (and potentially 
EPA) may effectively induce an ARA deficiency. When LA or ARA were included into dietary treatments, 
the levels of 20:3n-9/20:4n-6 were reduced, supporting the LA requirement previously reported (NRC 
2011); however, when LA was provided in the absence of ALA, (i.e., EFA Free (-) Control), Nile Tilapia 
exhibited significantly higher values of 22:5n-6/22:6n-3. This elevated level of the 22:5n-6/22:6n-3 ratio 
indicates a developing DHA deficiency, supporting previous claims made for the inclusion of both n-3 and 
n-6 fatty acids in the related hybrid Tilapia (Oreochromis niloticus ♀ x O. aureus ♂) (Chou 1999). Despite 
desirable effects of dietary LC-PUFA supplementation on the fatty acid composition of the edible tissues, 
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this study clearly demonstrated that Nile Tilapia can synthesize LC-PUFA from C18 PUFA in order to 
satisfy physiological demand and that dietary supplementation with DHA, in the absence of ARA, might 
lead to an n-6 LC-PUFA deficiency in this species.   
 Based on production performance results, one might conclude that the essential fatty acid 
requirements of Florida Pompano are 1) effectively met by either C18 PUFA or LC-PUFA, or 2) this 
species does not require any PUFA whatsoever.  The lack of significant differences in growth 
performance between the EFA-free (-) Control and various experimental treatments mask what I believe 
to be developing essential fatty acid deficiencies in at least some of these treatment groups.  First, growth 
performance was numerically, if not statistically, improved among fish fed the C18 PUFA supplemented 
feeds and further improved among fish fed combinations of LC-PUFAs.  It is possible that a longer 
feeding trial would have allowed these potential treatment effects to develop into statistical significance.  
Second, the fatty acid deficiency indicator ratios seem to suggest that essential fatty acid deficiency was 
developing in at least some of the dietary treatment groups.  Although the absence of 20:3n-9 could be 
indicative of a capacity to synthesize LC-PUFA, it is equally plausible that the limited amount of 18:1n-9 in 
the diets limited synthesis.  Elevated levels of the 22:5n-6/22:6n-3 ratio in both ARA+DHA and LC-PUFA 
treatments suggest there is some EFA limitation, but the elevated indicator ratios being observed in the 
ARA+DHA and LC-PUFA treatment groups is puzzling. In contrast to the low trophic level of Nile Tilapia, 
Florida Pompano occupy a much higher trophic position (trophic level = 3.5) (Froese and Pauly 2016), 
with much of their diet consisting largely of crustaceans and other benthic invertebrates. Based on their 
higher trophic level, I predicted that Florida Pompano lack the capacity to transform C18 PUFA into LC-
PUFA. Although there were no significant differences between any experimental treatment and the EFA-
Free control, performance was numerically superior among fish fed the ARA+DHA and LC-PUFA 
treatments. Of course, this conclusion is somewhat undercut by the observation of elevated 22:5n-
6/22:6n-3 ratios in these same treatments. Nonetheless, provision of LA and/or ALA did not appear to 
result in significant increases in tissue levels of ARA, EPA, or DHA (particularly in liver tissues, the 
primary site of LC-PUFA biosynthesis) as observed in Nile Tilapia, suggesting that de novo synthesis was 
absent or limited in Florida Pompano.  The requirement for LC-PUFA has been shown in many other 
species (Williams et al. 1985; Nematipour and Gatlin 1993; Craig and Gatlin 1995; Xu and Kestemont 
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2002; Luzzana et al. 2003; Mourente et al. 2006; Trushenski et al. 2011, 2012), most of these occupying 
similar or higher trophic levels compared to Florida Pompano. Tissue fatty acid composition was 
consistent with results of the Nile Tilapia study, with fish not provided with LC-PUFA in the diet (i.e., fish 
fed the ALA, C18 PUFA, and EFA Free Control feeds) exhibiting significantly lower levels of ARA, EPA, 
and DHA in comparison with fish fed these nutrients directly.  
 My results indicate that Nile Tilapia can utilize C18 PUFA to synthesize LC-PUFA, and both n-3 
and n-6 PUFA are required to meet the essential fatty acid requirements of Nile Tilapia. Other species 
with similar trophic levels including Grass Carp (freshwater, coolwater, trophic level = 2.0) (Froese and 
Pauly 2016), Milkfish (marine, tropical, trophic level = 2.4) (Froese and Pauly 2016), Common Carp 
(freshwater, coolwater, trophic level = 3.05) (Froese and Pauly 2016) and Channel Catfish (freshwater, 
coolwater, trophic level = 3.4) (Froese and Pauly 2016) all reportedly require C18 PUFA, but not LC-PUFA 
(NRC 2011). These species represent both freshwater and marine guilds and a variety of preferred 
thermal ranges, but similar fatty acid requirements. Additional studies must be conducted to quantitatively 
determine specific fatty acid requirements for individual species, but in the absence of such information, 
trophic levels may be a useful predictor of C18 PUFA vs. LC-PUFA essentiality and beneficial for guiding 
nutritional studies.  
 Further my results indicate that Florida Pompano have little-to-no capacity for LC-PUFA synthesis 
regardless of C18 PUFA availability. A requirement for dietary LC-PUFA has been reported in other 
carnivorous species including Striped Bass (anadromous, coolwater, trophic level = 4.04) (Froese and 
Pauly 2016), Atlantic Salmon (anadromous, coldwater, trophic level = 3.76) (Froese and Pauly 2016), 
Mahi Mahi (marine, warmwater, trophic level = 4.48) (Froese and Pauly 2016), Striped Jack 
(Pseudocaranx dentex; marine, warmwater, trophic level = 3.66) (Froese and Pauly 2016) and Yellowtail 
(Seriola quinqueradiata; marine, coolwater, trophic level = 3.96) (Froese and Pauly 2016) (NRC 2011). As 
noted for C18 PUFA requirements among lower trophic level species, requirements for LC-PUFA are not 
limited to freshwater or marine fish or species that prefer warm, cool, or cold water. As noted above, 
many individual studies may be needed to quantitatively determine taxonomically specific EFA 
requirements in untested species; however, one can expect all species to exhibit requirements for both n-
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3 and n-6 PUFA and trophic level appears to be a reliable indicator of C18 PUFA vs. LC-PUFA 
essentiality.   
 The goal of this research was to assess the essentiality of C18 PUFA or LC-PUFA in feeds for taxa 
representing freshwater/marine and omnivore/carnivore dichotomies, address the relative utility of thermal 
vs. salinity vs. trophic guilds as predictors of PUFA essentiality; and, if appropriate, facilitate better use of 
trophic level as predictor of fatty acid requirements of fish. In the course of my work, I demonstrated that 
both n-3 and n-6 PUFA are needed in the diets of Nile Tilapia and Florida Pompano.  Further, I 
demonstrated that whereas LC-PUFA are unnecessary, perhaps even detrimental in feeds for Nile 
Tilapia, direct dietary provision of LC-PUFA may be beneficial, if not necessary, for Florida Pompano.  
Given these differential results and the trophic levels of the species involved, it appears best to use 
trophic level as a predictor of LC-PUFA essentiality in lieu of preferred water temperatures or salinities.   
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Table 2.1.  Feed formulations for Nile Tilapia (based on previously validated feed formulations; Trushenski et al. 2009 and Mulligan and 
Trushenski 2013). All values expressed as g/kg feed.   
Ingredient (g/kg) 
Fish Oil 
(+) Control 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Menhaden fish meal1 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Soybean meal1 422.0 422.0 422.0 422.0 422.0 422.0 422.0 
Wheat bran 182.8 182.8 182.8 182.8 182.8 182.8 182.8 
Corn gluten meal 180.0 180.0 180.0 180.0 180.0 180.0 180.0 
Fish oil 51.0 0.0 0.0 0.0 0.0 0.0 0.0 
Hydrogenated soybean oil 0.0 51.0 31.0 41.0 46.0 41.0 36.0 
Hydrogenated soybean lecithin 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
18:2n-6 ethyl ester 0.0 0.0 0.0 10.0 0.0 0.0 0.0 
20:4n-6 ethyl ester 0.0 0.0 0.0 0.0 0.0 5.0 5.0 
18:3n-3 ethyl ester 0.0 0.0 10.0 10.0 0.0 0.0 0.0 
20:5n-3 ethyl ester 0.0 0.0 0.0 0.0 0.0 0.0 5.0 
22:6n-3 ethyl ester 0.0 0.0 0.0 0.0 5.0 5.0 5.0 
Sodium phosphate 15.0 15.0 15.0 15.0 15.0 15.0 15.0 
Dicalcium phosphate 15.0 15.0 15.0 15.0 15.0 15.0 15.0 
Vitamin premix 1.2 1.2 1.2 1.2 1.2 1.2 1.2 
Mineral premix 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Stay-C 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Choline chloride 6.0 6.0 6.0 6.0 6.0 6.0 6.0 
Carboxymethyl cellulose 20.0 20.0 20.0 20.0 20.0 20.0 20.0 
1 Solvent extracted.   
2 Estimates are based on purified fatty acid ethyl ester supplements and inclusion rates and fatty acid composition of menhaden fish oil, 
hydrogenated soybean oil, hydrogenated soybean lecithin and a fatty acid/crude lipid weight conversion factor of 0.93 (Weihrauch et al. 1977).  
Trace lipid content of other practical ingredients was not included in these calculations.   
3 Fatty acid supplements included in LC-PUFA diet include ARA, DHA, and EPA 
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Table 2.2. Proximate and fatty acid composition (means ± SE) of Nile Tilapia diets containing fish oil, hydrogenated soybean oil, or 
hydrogenated soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic 
acid (ARA), or eicosapentaenoic acid (EPA) 1 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Proximate composition g/kg, dry matter basis (except Dry Matter) 
Dry Matter 971 ± 0 978 ± 0 957 ± 18 966 ± 7 966 ± 0 962 ± 1 971 ± 2 
Protein 447 ± 12 441 ± 1 442 ± 2 473 ± 1 438 ± 2 440 ± 3 440 ± 2 
Lipid 88 ± 1 79 ± 1 83 ± 1 83 ± 2 84 ± 1 86 ± 1 88 ± 1 
Ash 96 ± 0 95 ± 1 96 ± 0 109 ± 0 96 ± 1 95 ± 0 96 ± 0 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 5.5 ± 0.1 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 
16:0 17.5 ± 0.2 13.9 ± 0.0 12.3 ± 0.1 11.0 ± 0.0 13.1 ± 0.0 12.2 ± 0.0 11.4 ± 0.0 
18:0 7.7 ± 0.1 61.7 ± 0.1 52.4 ± 0.4 41.1 ± 0.0 57.0 ± 0.2 51.5 ± 0.5 46.1 ± 0.1 
SFAa 32.3 ± 0.4 77.1 ± 0.2 66.1 ± 0.3 53.4 ± 0.1 71.4 ± 0.2 65.1 ± 0.4 58.6 ± 0.1 
16:1 7.1 ± 0.1 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 
18:1n-7 2.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.4 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 
18:1n-9 9.2 ± 0.1 5.2 ± 0.0 5.1 ± 0.1 5.1 ± 0.0 5.1 ± 0.0 5.1 ± 0.1 5.0 ± 0.0 
MUFAb 19.8 ± 0.2 6.0 ± 0.0 5.8 ± 0.1 6.0 ± 0.0 5.9 ± 0.0 5.8 ± 0.1 5.8 ± 0.0 
18:2n-6 17.1 ± 0.1 14.8 ± 0.1 15.2 ± 0.2 26.1 ± 0.1 14.7 ± 0.1 14.9 ± 0.3 14.9 ± 0.0 
20:4n-6 0.8 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.0 0.0 ± 0.0 6.0 ± 0.1 6.4 ± 0.0 
n-6c 18.6 ± 0.1 14.8 ± 0.1 15.2 ± 0.2 26.2 ± 0.0 14.7 ± 0.1 20.9 ± 0.3 21.3 ± 0.1 
18:3n-3 2.7 ± 0.0 1.5 ± 0.0 12.3 ± 0.1 13.1 ± 0.1 1.5 ± 0.0 1.6 ± 0.0 1.6 ± 0.0 
18:4n-3 2.4 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
20:4n-3 1.1 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
20:5n-3 9.2 ± 0.2 0.1 ± 0.0 0.2 ± 0.0 0.3 ± 0.0 0.0 ± 0.0 0.2 ± 0.0 6.3 ± 0.0 
22:5n-3 1.6 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
22:6n-3 10.4 ± 0.3 0.4 ± 0.0 0.5 ± 0.0 0.9 ± 0.0 6.4 ± 0.0 6.5 ± 0.1 6.4 ± 0.0 
n-3d 27.3 ± 0.7 2.1 ± 0.0 12.9 ± 0.1 14.4 ± 0.1 8.1 ± 0.0 8.2 ± 0.1 14.3 ± 0.1 
PUFAe 47.9 ± 0.6 16.9 ± 0.1 28.1 ± 0.3 40.6 ± 0.0 22.8 ± 0.1 29.1 ± 0.3 35.6 ± 0.1 
C18 PUFAf 22.7 ± 0.1 16.4 ± 0.1 27.5 ± 0.3 39.2 ± 0.0 16.2 ± 0.1 16.5 ± 0.3 16.5 ± 0.0 
LC-PUFAg 23.5 ± 0.6 0.5 ± 0.0 0.6 ± 0.0 1.4 ± 0.0 6.6 ± 0.0 12.6 ± 0.2 19.0 ± 0.1 
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Table 2.2. Proximate and fatty acid composition (means ± SE) of Nile Tilapia diets containing fish oil, hydrogenated soybean oil, or hydrogenated 
soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA) 1 
a Saturated fatty acids—sum of all fatty acids without double bonds; include 15:0, 17:0, 20:0, 22:0, 21:0, 22:0, 23:0 and 24:0 in addition to individually 
reported SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond; include 14:1, 15:1, 17:1, 20:1n-9, 22:1n-11, 22:1n-9 and 24:1n-9 in  
addition to individually reported MUFA 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 16:2n-4, 16:3n-4, 18:2n-6 tans, 18:3n-6, 18:3n-4, 20:2, 20:3n-9, 
20:3n-6, 22:2 and 22:5n-6 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms  
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
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Table 2.3. Fatty acid composition of Nile Tilapia feeds (g fatty acid/kg feed); Reported Requirement (NRC 2011) adjusted from % dry diet to g 
fatty acid/kg feed 
 
Reported 
Requirement 
FISH OIL  
(+) CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
18:2n-6 5.0 14.0 10.9 11.7 20.1 11.5 11.9 12.2 
20:4n-6 n/a 0.7 0.0 0.0 0.0 0.0 4.8 5.2 
18:3n-3 n/a 2.2 1.1 9.5 10.1 1.2 1.3 1.3 
20:5n-3 n/a 7.5 0.1 0.2 0.2 0.0 0.2 5.2 
22:6n-3 n/a 8.5 0.3 0.4 0.7 5.0 5.2 5.2 
C18 PUFA n/a 16.2 12.0 21.2 30.3 12.7 13.2 13.5 
n-3 LC-
PUFA 
n/a 16.0 0.4 0.5 0.9 5.0 5.4 10.4 
Total LC-
PUFA 
n/a 16.7 0.4 0.5 1.0 5.0 10.2 15.6 
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Table 2.4.  Production performance of Nile Tilapia fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated soybean oil amended 
with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or eicosapentaenoic acid 
(EPA)  
Parameter 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Pooled 
SE 
P Value 
Survival 
(%) 
97.5 100 95 100 92.5 97.5 97.5 3.1 0.227 
Initial weight 
(g) 
25.8 25.7 25.6 25.6 25.7 25.9 25.7 0.1 0.605 
Final weight 
(g) 
134.3 z 108.6 y 117.3 zy 125.6 zy 112.0 y 113.0 y 119.5 zy 6.2 0.007 
Weight gain 
(%) 
421.4 z 322.8 y 358.2 zy 390.6 zy 335.5 y 337.2 y 365.5 zy 23.6 0.006 
SGR 
(% body 
weight/day) 
3.3 z 2.9 y 3.0 zy 3.2 zy 2.9 y 2.9 y 3.1 zy 0.1 0.007 
FCR  
(dry matter basis) 
1.0 y 1.2 z 1.2 z 1.1 zy 1.1 z 1.2 z 1.2 z 0.0 0.001 
Feed Intake 
(% body 
weight/day) 
3.6 3.6 3.9 3.8 3.7 3.7 3.9 0.2 0.308 
HSI  0.9 0.8 0.8 0.8 0.9 0.9 1.0 0.1 0.672 
LSI 6.2 6.5 6.1 6.4 10.0 6.6 6.9 1.7 0.300 
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Table 2.5. Fatty acid composition of fillet tissue of Nile Tilapia fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated soybean 
oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA) 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA Pooled SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 3.0 z 1.8 y 1.7 y 1.8 y 1.7 y 1.5 y 1.6 y 0.2 < 0.001 
16:0 21.5 23.9 22.2 21.8 21.9 22.2 21.3 0.9 0.122 
18:0 9.7 x 11.3 zy 11.7 zy 10.5 yx 11.5 zy 12.1 z 11.8 zy 0.4 < 0.001 
SFAa 35.2 y 38.0 z 36.3 zy 34.8 y 36.0 zy 36.6 zy 35.4 zy 0.8 0.015 
16:1 4.0 z 2.3 y 2.0 y 2.4 y 1.9 y 2.0 y 2.0 y 0.4 < 0.001 
18:1n-7 3.7 y 3.9 z 3.1 wv 2.9 v 3.4 x 3.2 xw 2.9 v 0.1 < 0.001 
18:1n-9 10.4 13.2 13.4 13.5 13.7 12.1 12.9 1.6 0.452 
MUFAb 19.2 20.8 19.6 19.9 21.6 18.5 19.0 2.1 0.783 
18:2n-6 9.2 w 12.0 y 11.7 y 16.2 z 11.5 yx 9.9 xw 9.6 w 0.5 < 0.001 
20:3n-6 0.7 x 1.4 z 1.2 zy 1.3 zy 1.1 y 0.7 x 0.6 x 0.1 < 0.001 
20:4n-6 2.3 x 5.3 y 3.7 x 3.6 x 3.1 x 8.2 z 7.7 z 0.5 < 0.001 
22:5n-6 0.9 w 3.9 z 1.7 x 1.9 x 1.6 x 2.6 y 1.7 x 0.1 < 0.001 
n-6c 13.4 w 23.3 z 18.9 x 23.7 z 17.7 x 21.8 zy 20.0 yx 0.8 < 0.001 
18:3n-3 1.1 y 0.7 y 5.4 z 5.3 z 0.8 y 0.8 y 0.8 y 0.2 < 0.001 
20:5n-3 2.8 z 0.9 xw 1.1 x 0.8 xw 0.8 xw 0.7 w 1.9 y 0.1 < 0.001 
22:5n-3 5.4 z 2.2 wv 2.9 x 2.3 xw 1.5 vu 1.5 u 4.0 y 0.2 < 0.001 
22:6n-3 20.3 z 11.9 x 13.8 yx 11.2 x 19.9 z 18.7 zy 17.8 zy 1.6 < 0.001 
n-3d 30.9 z 15.8 x 23.7 y 19.9 yx 23.2 y 21.7 y 24.5 y 1.8 < 0.001 
20:3n-9 0.1 x 0.6 z 0.3 zyx 0.3 yx 0.4 zy 0.2 yx 0.2 yx 0.1 < 0.001 
PUFAe 45.6 41.2 44.1 45.2 42.5 44.9 45.6 2.4 0.451 
C18 PUFAf 11.3 wv 13.6 x 17.9 y 22.4 z 12.9 xw 11.1 wv 10.9 v 0.6 < 0.001 
LC-PUFAg 33.2 zy 26.3 yx 25.1 x 21.6 x 28.5 zyx 32.7 zy 33.9 z 2.3 < 0.001 
n-3:n-6 2.3 z 0.7 v 1.3 yx 0.8 wv 1.3 y 1.0 xw 1.2 yx 0.1 < 0.001 
20:3n9 : 
20:4n-6 0.036 y 0.127 z 0.095 zy 0.079 zy 0.143 z 0.026 y 0.026 y 0.024 < 0.001 
22:5n-6 : 
22:6n-3 0.043 w 0.353 z 0.128 yx 0.180 y 0.083 xw 0.148 yx 0.101 yxw 0.024 < 0.001 
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Table 2.5, continued. 
a Saturated fatty acids—sum of all fatty acids without double bonds; include 15:0, 17:0, 20:0, 22:0 and 24:0 in addition to individually reported 
SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 14:1, 15:1, 16:1, 16:2n-4, 16:3n-4, 17:1, 18:3n-6, 18:3n-4, 
18:4n-3, 20:1n-9, 20:2, 20:3n-6, 
20:4n-3, 22:1n-9 and 24:1n-9 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 
3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
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Table 2.6.  Fatty acid composition of liver tissue of Nile Tilapia fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated soybean 
oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA) 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA Pooled SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 2.8 z 2.1 zy 1.8 y 1.8 y 1.7 y 1.7 y 1.6 y 0.2 0.001 
16:0 21.6 23.2 22.1 22.0 23.0 21.8 21.4 0.9 0.329 
18:0 14.1 16.8 16.2 16.7 16.4 16.7 16.5 1.1 0.239 
SFAa 39.8 43.1 41.1 41.5 42.2 41.2 40.5 1.6 0.486 
16:1 3.6 z 2.2 y 1.6 y 1.9 y 1.7 y 1.9 y 1.7 y 0.3 < 0.001 
18:1n-7 2.9 z 3.0 z 2.2 y 2.3 y 2.4 y 2.4 y 2.3 y 0.1 < 0.001 
18:1n-9 10.2 10.7 10.4 11.1 10.8 9.7 10.1 1.1 0.900 
MUFAb 17.9 17.0 15.3 16.3 16.1 15.2 15.2 1.4 0.390 
18:2n-6 6.7 zy 6.3 zy 7.0 zy 8.3 z 5.6 zy 5.2 y 5.0 y 0.8 0.010 
20:3n-6 0.8 y 1.5 z 1.3 z 1.5 z 1.2 z 0.8 y 0.8 y 0.1 < 0.001 
20:4n-6 3.9 v 9.1 zy 7.2 xw 7.8 yx 6.3 w 9.6 z 9.2 z 0.4 < 0.001 
22:5n-6 0.9 w 6.9 z 2.7 x 3.5 yx 2.6 x 4.4 y 3.0 yx 0.5 < 0.001 
n-6c 12.6 v 24.3 z 18.5 x 21.5 y 16.1 w 20.3 yx 18.2 xw 0.1 < 0.001 
18:3n-3 0.7 y 0.3 y 2.4 z 1.9 z 0.4 y 0.4 y 0.4 y 0.2 < 0.001 
20:5n-3 1.5 z 0.2 x 0.6 yx 0.4 yx 0.3 x 0.2 x 0.7 y 0.1 < 0.001 
22:5n-3 3.7 z 1.0 w 1.9 yx 1.4 xw 0.7 w 0.8 w 2.3 y 0.2 < 0.001 
22:6n-3 21.8 z 12.1 x 18.3 yx 15.2 yx 22.5 z 20.5 z 21.5 z 1.5 < 0.001 
n-3d 28.4 z 13.6 w 23.5 zyx 19.2 x 23.9 zyx 22.0 yx 25.0 zy 1.8 < 0.001 
20:3n-9 0.2 x 1.0 z 0.6 zyx 0.4 yx 0.8 zy 0.4 yx 0.4 yx 0.1 < 0.001 
PUFAe 42.3 39.9 43.6 42.2 41.7 43.6 44.4 2.1 0.445 
C18 PUFAf 2.3 z 0.6 v 1.3 yx 0.9 w 1.5 y 1.1 xw 1.4 yx 0.1 < 0.001 
LC-PUFAg 33.2 zyx 31.8 yx 32.8 zyx 30.4 x 34.5 zyx 36.8 zy 37.9 z 1.8 0.006 
n-3:n-6 8.1 zyx 7.1 yx 9.8 zy 10.7 z 6.3 x 5.9 x 5.7 x 1.0 < 0.001 
20:3n9 : 20:4n-
6 0.044 x 0.109 zy 0.076 zyx 0.058 yx 0.126 z 0.045 x 0.040 x 0.018 < 0.001 
22:5n-6 : 
22:6n-3 0.042 x 0.582 z 0.152 yx 0.237 y 0.119 yx 0.221 y 0.143 yx 0.039 < 0.001 
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Table 2.6, continued.   
a Saturated fatty acids—sum of all fatty acids without double bonds; include 15:0, 17:0, 20:0, 22:0 and 24:0 in addition to individually reported SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 14:1, 15:1, 16:1, 16:2n-4, 16:3n-4, 17:1, 18:3n-6, 18:3n-4, 
18:4n-3, 20:1n-9, 20:2, 20:3n-6,  
20:4n-3, 22:1n-9 and 24:1n-9 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
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Table 2.7.  Fatty acid composition of intraperitoneal fat of Nile Tilapia fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated 
soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA) 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA Pooled SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 6.3 zy 6.5 z 4.8 zyx 4.2 x 5.0 zyx 4.6 yx 4.6 yx 0.6 0.002 
16:0 22.2 x 27.4 z 24.1 yx 23.2 yx 25.7 zy 23.8 yx 22.4 x 1.0 0.003 
18:0 8.2 x 13.0 z 11.5 zy 10.0 yx 11.7 zy 11.5 zy 10.8 zyx 0.9 < 0.001 
21:0 0.7 y 1.3 y 1.0 y 0.9 y 0.9 y 3.2 z 3.1 z 0.2 < 0.001 
SFAa 38.6 x 49.6 z 42.3 yx 39.1 x 44.3 y 44.2 y 41.8 yx 1.3 0.001 
16:1 7.8 z 5.5 y 4.8 y 4.6 y 4.9 y 5.0 y 4.9 y 0.4 < 0.001 
18:1n-7 3.6 zy 3.9 z 3.1 yx 2.9 x 3.5 zy 3.3 yx 3.1 yx 0.2 < 0.001 
18:1n-9 15.4 y 18.4 zy 20.0 z 18.8 zy 20.2 z 18.9 zy 19.6 z 1.3 0.022 
20:1n-9 1.0 x 1.8 z 1.4 zyx 1.2 yx 1.6 zy 1.4 zyx 1.4 zyx 0.1 < 0.001 
22:1n-11 0.6 2.0 1.0 0.8 1.3 1.2 1.2 0.5 0.144 
MUFAb 29.0 32.5 30.9 28.8 32.2 30.4 30.8 1.5 0.144 
18:2n-6 12.1 y 10.1 y 11.7 y 17.7 z 12.7 y 13.0 y 12.5 y 1.2 < 0.001 
20:4n-6 0.2 y 0.1 y 0.9 z 0.8 z 0.2 y 0.2 y 0.1 y 0.1 < 0.001 
22:5n-6 0.3 w 0.6 zy 0.3 xw 0.4 yxw 0.4 xw 0.8 z 0.6 zyx 0.1 < 0.001 
n-6c 13.5 y 12.0 y 14.0 y 20.4 z 14.2 y 14.9 y 14.1 y 1.3 < 0.001 
18:3n-3 1.6 y 0.1 y 6.1 z 6.2 z 0.1 y 1.1 y 1.1 y 0.0 < 0.001 
20:5n-3 1.7 z 0.3 x 0.4 x 0.3 x 0.3 x 0.4 x 1.2 y 0.1 < 0.001 
22:5n-3 4.8 z 1.5 x 1.8 x 1.4 x 1.5 x 2.0 x 3.7 y 0.3 < 0.001 
22:6n-3 7.1 z 1.7 x 2.5 x 2.1 x 4.7 y 5.3 y 5.6 zy 0.5 < 0.001 
n-3d 17.0 z 4.4 w 11.4 y 10.4 yx 7.9 x 9.1 yx 12.0 y 1.0 < 0.001 
20:3n-9 0.1 y 0.2 z 0.2 zy 0.2 zy 0.2 z 0.1 zy 0.2 zy 0.0 0.025 
PUFAe 32.4 z 17.9 x 26.8 zy 32.2 z 23.5 yx 25.5 y 27.4 zy 2.0 < 0.001 
C18 PUFAf 15.3 yx 11.5 x 18.7 y 24.9 z 14.4 yx 14.7 yx 14.3 yx 1.4 < 0.001 
LC-PUFAg 15.6 z 5.1 v 7.0 xwv 6.1 wv 8.0 xw 9.5 yx 12.1 y 0.9 < 0.001 
n-3:n-6 1.3 z 0.4 w 0.8 y 0.5 xw 0.6 x 0.6 x 0.9 y 0.0 < 0.001 
20:3n9 : 20:4n-
6 0.266 y 1.593 z 0.194 y 0.193 y 1.386 z 0.937 zy 1.344 z 0.312 < 0.001 
22:5n-6 : 
22:6n-3 0.043 t 0.378 z 0.134 xw 0.204 y 0.079 vt 0.153 x 0.103 wv 0.015 < 0.001 
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Table 2.7, continued.  
a Saturated fatty acids—sum of all fatty acids without double bonds; include 15:0, 17:0, 20:0, 22:0 and 24:0 in addition to individually reported SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 14:1, 15:1, 16:1, 16:2n-4, 16:3n-4, 17:1, 18:3n-6, 18:3n-4, 
18:4n-3, 20:1n-9, 20:2, 20:3n-6,  
20:4n-3, 22:1n-9 and 24:1n-9 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
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Table 2.8.  Fatty acid composition of brain tissue of Nile Tilapia fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated soybean 
oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA) 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA Pooled SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 4.4 z 2.4 y 2.4 y 2.6 y 2.5 y 2.6 y 2.3 y 0.3 < 0.001 
16:0 21.8 23.3 21.9 22.0 22.5 22.6 21.4 0.7 0.246 
18:0 11.2 y 14.2 z 13.8 zy 12.6 zy 13.3 zy 13.7 zy 13.8 zy 0.9 0.037 
24:0 1.3 1.8 1.8 1.4 1.5 1.5 1.6 0.2 0.323 
SFAa 39.9 42.9 40.9 39.5 40.8 41.5 40.1 1.4 0.328 
16:1 6.4 z 3.9 y 3.7 y 4.0 y 3.8 y 4.2 y 3.6 y 0.3 < 0.001 
18:1n-7 3.1 z 2.7 zy 2.4 y 2.5 y 2.7 zy 2.7 zy 2.4 y 0.1 < 0.001 
18:1n-9 18.6 y 21.4 z 21.7 z 20.4 zy 21.4 z 21.1 z 20.5 zy 0.7 0.008 
MUFAb 30.0 30.0 29.5 29.7 29.8 29.8 28.3 0.9 0.396 
18:2n-6 8.5 y 7.4 y 7.6 y 12.4 z 9.1 y 9.3 zy 8.4 y 1.0 0.001 
20:4n-6 1.2 w 2.8 y 2.1 x 1.8 xw 1.8 xw 3.6 z 3.8 z 0.2 < 0.001 
22:5n-6 0.3 v 0.9 z 0.4 wv 0.5 xw 0.4 xwv 0.6 y 0.5 yx 0.0 < 0.001 
n-6c 10.7 x 12.2 yx 11.0 yx 15.9 z 12.2 yx 14.2 zy 13.5 zyx 1.0 < 0.001 
18:3n-3 1.1 y 0.6 y 4.2 z 4.3 z 0.8 y 0.8 y 0.8 y 0.3 < 0.001 
20:5n-3 1.4 z 0.5 y 0.5 y 0.5 y 0.5 y 0.4 y 1.2 z 0.2 < 0.001 
22:5n-3 3.5 z 1.3 y 1.6 y 1.4 y 1.4 y 1.3 y 2.8 z 0.2 < 0.001 
22:6n-3 10.8 zy 11.2 zy 10.9 zy 8.1 y 13.0 z 10.7 zy 12.2 z 1.2 0.026 
n-3d 18.0 z 13.8 zy 17.6 zy 14.8 zy 16.0 zy 13.4 y 17.3 zy 1.4 0.010 
20:3n-9 0.1 y 0.2 z 0.1 zy 0.1 zy 0.2 z 0.1 zy 0.1 zy 0.0 0.001 
PUFAe 30.2 27.1 29.5 31.8 29.4 28.6 31.6 1.9 0.227 
C18 PUFAf 10.8 y 8.8 y 12.6 y 17.6 z 10.5 y 10.7 y 9.8 y 1.2 < 0.001 
LC-PUFAg 18.3 zy 17.5 zyx 16.3 yx 13.3 x 18.0 zyx 17.2 zyx 21.2 z 1.5 0.003 
n-3 : n-6 1.7 z 1.2 zy 1.6 z 1.0 y 1.5 zy 1.0 y 1.4 zy 0.20 < 0.001 
20:3n9 : 20:4n-
6 0.047 yx 0.109 zy 0.074 zyx 0.081 zyx 0.136 z 0.034 yx 0.030 x 0.024 0.002 
22:5n-6 : 
22:6n-3 0.025 w 0.101 z 0.035 xw 0.064 yx 0.033 w 0.071 zy 0.045 yxw 0.009 < 0.001 
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Table 2.8, continued.   
a Saturated fatty acids—sum of all fatty acids without double bonds; include 15:0, 17:0, 20:0, 22:0 and 24:0 in addition to individually reported 
SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 14:1, 15:1, 16:1, 16:2n-4, 16:3n-4, 17:1, 18:3n-6, 18:3n-4, 
18:4n-3, 20:1n-9, 20:2, 20:3n-6,  
20:4n-3, 22:1n-9 and 24:1n-9 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 
3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
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Table 2.9.  Fatty acid composition of eye tissue of Nile Tilapia fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated soybean 
oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA) 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA 
Pooled 
SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 5.7 z 4.7 y 4.0 x 3.6 wv 3.9 xw 3.7 xwv 3.5 v 0.1 < 0.001 
16:0 19.1 x 23.2 z 20.3 yx 19.3 yx 21.3 zy 20.1 yx 18.9 x 0.6 < 0.001 
18:0 6.4 w 8.1 y 8.6 zy 7.5 x 8.8 z 8.7 zy 8.5 zy 0.2 < 0.001 
SFAa 32.2 xw 36.9 z 33.5 yx 31.1 w 34.8 zy 33.3 yx 31.7 xw 0.7 < 0.001 
16:1 7.9 z 6.1 y 5.1 x 5.0 x 5.1 x 5.3 x 4.9 x 0.2 < 0.001 
18:1n-7 3.5 zy 3.7 z 3.0 xw 2.8 w 3.3 yx 3.1 yxw 2.9 w 0.1 < 0.001 
18:1n-9 15.0 y 20.3 z 19.7 z 18.1 zy 20.4 z 18.6 z 18.4 z 1.0 < 0.001 
20:1n-9 0.9 y 1.3 z 1.1 zy 1.0 y 1.3 z 1.1 zy 1.0 y 0.1 < 0.001 
MUFAb 28.2 y 32.4 z 29.9 zy 27.7 y 31.0 zy 29.0 zy 28.0 y 1.2 0.008 
18:2n-6 12.9 y 16.2 y 15.2 y 20.6 z 16.5 y 16.6 y 15.0 y 1.2 < 0.001 
20:4n-6 0.8 y 1.2 y 0.9 y 1.0 y 0.9 y 4.2 z 4.3 z 0.2 < 0.001 
22:5n-6 0.3 w 0.7 y 0.3 w 0.5 x 0.4 xw 0.9 z 0.7 y 0.0 < 0.001 
n-6c 15.1 w 20.0 zyx 17.8 xw 23.9 z 19.1 yxw 23.0 zy 21.2 zyx 1.3 < 0.001 
18:3n-3 1.8 x 1.4 x 9.0 z 7.9 y 1.5 x 1.5 x 1.4 x 0.2 < 0.001 
20:5n-3 2.6 z 0.9 x 0.9 x 0.8 x 0.7 x 0.9 x 2.2 y 0.1 < 0.001 
22:6n-3 9.8 z 3.6 x 4.0 x 3.9 x 8.6 y 8.0 y 8.6 zy 0.4 < 0.001 
n-3d 22.5 z 8.7 w 17.3 y 15.6 y 13.4 x 13.2 x 17.8 y 0.7 < 0.001 
20:3n-9 0.1 y 0.3 z 0.2 zy 0.2 zy 0.3 z 0.2 zy 0.2 zy 0.0 < 0.001 
PUFAe 39.6 zy 30.8 x 36.6 zyx 41.2 z 34.2 yx 37.7 zy 40.3 z 1.8 < 0.001 
C18 PUFAf 16.7 y 19.2 y 25.6 z 30.1 z 19.0 y 19.1 y 17.4 y 1.4 < 0.001 
LC-PUFAg 21.3 z 10.0 w 9.8 w 9.8 w 13.8 x 17.3 y 21.8 z 0.7 < 0.001 
n-3 : n-6 1.5 z 0.4 u 1.0 y 0.7 wv 0.7 w 0.6 v 0.8 x 0.00 < 0.001 
20:3n9 : 20:4n-6 0.074 yx 0.258 z 0.228 z 0.185 zy 0.305 z 0.042 x 0.039 x 0.041 < 0.001 
22:5n-6 : 22:6n-3 0.036 v 0.203 z 0.086 xw 0.131 y 0.052 wv 0.120 yx 0.082 w 0.011 < 0.001 
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Table 2.9, continued.   
a Saturated fatty acids—sum of all fatty acids without double bonds; include 15:0, 17:0, 20:0, 22:0 and 24:0 in addition to individually reported 
SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 14:1, 15:1, 16:1, 16:2n-4, 16:3n-4, 17:1, 18:3n-6, 18:3n-4, 
18:4n-3, 20:1n-9, 20:2, 20:3n-6,  
20:4n-3, 22:1n-9 and 24:1n-9 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 
3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
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Table 2.10. Coefficient of distance values of tissues of Nile Tilapia fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated 
soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA) 
 
FISH OIL  
(+) CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Fillet 0.0 11.5 9.9 13.5 6.8 8.7 7.5 
Liver 0.0 13.4 6.6 9.4 5.8 8.4 7.0 
Brain 0.0 6.3 6.6 6.8 5.4 5.8 5.5 
Eye 0.0 10.2 11.5 12.6 8.3 7.9 7.0 
Intraperitoneal fat 0.0 8.6 8.3 9.2 7.8 6.7 6.5 
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Table 3.1.  Feed formulations for Florida Pompano (based on previously validated feed formulations; Trushenski et al. 2011). All values 
expressed as g/kg feed.   
Ingredient (g/kg) 
Fish Oil 
(+) Control 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Menhaden fish meal1 245.5 245.5 245.5 245.5 245.5 245.5 245.5 
Soybean protein concentrate 137.0 137.0 137.0 137.0 137.0 137.0 137.0 
Soy protein isolate 79.2 79.2 79.2 79.2 79.2 79.2 79.2 
Wheat bran 277.3 277.3 277.3 277.3 277.3 277.3 277.3 
Corn gluten meal 150.0 150.0 150.0 150.0 150.0 150.0 150.0 
Fish oil 72.7 0.0 0.0 0.0 0.0 0.0 0.0 
Hydrogenated soybean oil 0.0 72.7 62.8 52.9 67.7 62.7 57.7 
Hydrogenated soybean 
lecithin 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
18:2n-6 ethyl ester 0.0 0.0 0.0 9.9 0.0 0.0 0.0 
20:4n-6 ethyl ester 0.0 0.0 0.0 0.0 0.0 5.0 5.0 
18:3n-3 ethyl ester 0.0 0.0 9.9 9.9 0.0 0.0 0.0 
20:5n-3 ethyl ester 0.0 0.0 0.0 0.0 0.0 0.0 5.0 
22:6n-3 ethyl ester 0.0 0.0 0.0 0.0 5.0 5.0 5.0 
Vitamin premix 1.2 1.2 1.2 1.2 1.2 1.2 1.2 
Mineral premix 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Stay-C 1.8 1.8 1.8 1.8 1.8 1.8 1.8 
Methionine chloride 3.3 3.3 3.3 3.3 3.3 3.3 3.3 
Choline chloride 6.0 6.0 6.0 6.0 6.0 6.0 6.0 
Carboxymethyl cellulose 20.0 20.0 20.0 20.0 20.0 20.0 20.0 
1 Solvent extracted.   
2 Estimates are based on purified fatty acid ethyl ester supplements and inclusion rates and fatty acid composition of menhaden fish oil, 
hydrogenated soybean oil, hydrogenated soybean lecithin and a fatty acid/crude lipid weight conversion factor of 0.93 (Weihrauch et al. 1977).  
Trace lipid content of other practical ingredients was not included in these calculations.   
3LC-PUFA diet amended with ARA, DHA, and EPA 
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Table 3.2. Proximate and fatty acid composition (means ± SE) of Florida Pompano diets containing fish oil, hydrogenated soybean oil, or 
hydrogenated soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic 
acid (ARA), or eicosapentaenoic acid (EPA)h 
 
FISH OIL  
(+) CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Proximate 
composition 
g/kg, dry matter basis (except Dry Matter) 
Dry Matter 951.3 ± 0.0   963.3 ± 0.1  962.6 ± 0.3  959.1 ± 0.2 954.2 ± 0.2  954.2 ± 0.1   953.2 ± 0.2 
Protein 571.9 ± 3.9 568.8 ± 3.0 566.9 ± 3.9  566.3 ± 2.7 568.6 ± 4.9  562.2 ± 2.8 566.0 ± 1.2 
Lipid 108.4 ± 1.1  102.1 ± 0.8  104.1 ± 1.8  106.2 ± 0.6 103.4 ± 1.1  104.0 ± 1.0  105.1 ± 0.6  
Ash 94.8 ± 1.0  95.3 ± 0.2 94.0 ± 0.9  95.7 ± 0.3 94.8 ± 0.3  95.7 ± 0.4 94.8 ± 0.2 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 6.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 
16:0 17.8 ± 0.0 13.3 ± 0.0 12.1 ± 0.0 11.0 ± 0.0 12.7 ± 0.0 12.0 ± 0.0 11.5 ± 0.0 
18:0 6.7 ± 0.0 70.0 ± 0.2 61.8 ± 0.2 53.1 ± 0.2 65.9 ± 0.3 61.7 ± 0.2 57.4 ± 0.0 
SFAa 32.5 ± 0.2 84.7 ± 0.2 75.2 ± 0.2 65.2 ± 0.2 80.0 ± 0.3 75.1 ± 0.2 70.2 ± 0.1 
16:1 8.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 
18:1n-7 2.5 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 
18:1n-9 8.6 ± 0.1 3.9 ± 0.1 3.9 ± 0.0 4.0 ± 0.0 3.9 ± 0.1 3.9 ± 0.1 4.0 ± 0.1 
MUFAb 21.0 ± 0.0 4.6 ± 0.1 4.5 ± 0.1 4.7 ± 0.0 4.6 ± 0.1 4.5 ± 0.1 4.5 ± 0.0 
18:2n-6 12.3 ± 0.1 9.6 ± 0.1 9.9 ± 0.1 19.4 ± 0.0 9.6 ± 0.2 9.5 ± 0.1 9.8 ± 0.1 
20:4n-6 0.9 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 4.9 ± 0.0 4.9 ± 0.0 
n-6c 13.9 ± 0.1 9.6 ± 0.1 9.9 ± 0.1 19.4 ± 0.1 9.6 ± 0.2 14.4 ± 0.1 14.8 ± 0.1 
18:3n-3 2.0 ± 0.0 0.7 ± 0.0 9.9 ± 0.0 10.1 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 
18:4n-3 2.8 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
20:4n-3 1.3 ± 0.0 0.0 ± 00 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
20:5n-3 10.6 ± 0.0 0.1 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 4.7 ± 0.0 
22:5n-3 1.8 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
22:6n-3 11.9 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.4 ± 0.0 4.9 ± 0.0 5.1 ± 0.0 5.0 ± 0.0 
n-3d 30.4 ± 0.0 1.2 ± 0.0 10.4 ± 0.0 10.6 ± 0.0 5.7 ± 0.0 5.9 ± 0.0 10.5 ± 0.1 
PUFAe 46.6 ± 0.1 10.8 ± 0.2 20.3 ± 0.1 30.1 ± 0.1 15.4 ± 0.2 20.4 ± 0.1 25.2 ± 0.0 
C18 PUFAf 17.6 ± 0.1 10.3 ± 0.1 19.7 ± 0.1 29.5 ± 0.1 10.3 ± 0.2 10.2 ± 0.1 10.5 ± 0.1 
LC-PUFAg 27.0 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 0.6 ± 0.0 5.0 ± 0.0 10.1 ± 0.0 14.7 ± 0.1 
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Table 3.2, continued.   
a. Saturated fatty acids—sum of all fatty acids without double bonds; include 12:0, 13:0, 15:0, 17:0, 20:0, 21:0, 22:0, 21:0, 22:0, 23:0 and 24:0 in 
addition to individually reported SFA 
b. Monounsaturated fatty acids—sum of all fatty acids with a single double bond; include 14:1, 15:1, 17:1, 20:1n-9, 22:1n-11, 22:1n-9 and 24:1n-
9 in addition to individually reported MUFA 
c. Sum of all n-6 fatty acids 
d. Sum of all n-3 fatty acids 
e. Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 16:2n-4, 16:3n-4, 18:3n-6, 18:3n-4, 20:2, 20:3n-9, 20:3n-6, 
22:2 and 22:5n-6 in addition to individually reported PUFA 
f. Sum of all PUFA with chain lengths of 18 carbon atoms 
g. Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
h. LC-PUFA diet amended with ethyl esters of DHA, ARA, and EPA 
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Table 3.3. Fatty acid content of Florida Pompano feeds (g fatty acid/kg feed); Reported Requirements (NRC 2011) for Florida Pompano 
currently undetermined (n/d).  
 
Reported 
Requirement 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
18:2n-6 n/d 12.4 9.1 9.6 19.2 9.2 9.2 9.6 
20:4n-6 n/d 0.9 0.0 0.0 0.0 0.0 4.7 4.8 
18:3n-3 n/d 2.0 0.7 9.6 10.0 0.7 0.7 0.7 
20:5n-3 n/d 10.7 0.1 0.2 0.2 0.2 0.2 4.6 
22:6n-3 n/d 12.0 0.3 0.3 0.4 4.7 4.9 4.9 
C18 PUFA n/d 14.4 9.8 19.2 29.1 9.9 9.9 10.3 
n-3 LC-PUFA n/d 22.7 0.4 0.5 0.6 4.9 5.1 9.5 
Total LC-PUFA n/d 23.6 0.4 0.5 0.6 4.9 9.9 14.3 
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Table 3.4. Production performance of Florida Pompano fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated soybean oil 
amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA).  No mortalities were observed, therefore survival data were not analyzed (NA) using formal statistics.  
Parameter 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Pooled 
SE 
P Value 
Survival 
(%) 
100 100 100 100 100 100 100 NA NA 
Initial weight 
(g) 
47.6 47.4 47.2 47.3 46.7 47.7 47.7 0.5 0.400 
Final weight 
(g) 
153.8 z 117.2 y 121.2 y 124.3 y 119.8 y 130.1 y 130.1 y 4.0 < 0.001 
Weight gain 
(%) 
223.4 z 147.1 y 156.9 y 162.5 y 156.8 y 173.0 y 172.9 y 8.6 < 0.001 
SGR 
(% body 
weight/day) 
2.1 z 1.6 y 1.7 y 1.7 y 1.7 y 1.8 y 1.8 y 0.1 < 0.001 
FCR  
(dry matter basis) 
1.4 y 2.2 z 2.1 z 2.0 z 2.1 z 1.8 z 1.8 z 0.1 < 0.001 
Feed Intake 
(% body 
weight/day) 
3.1 y 3.6 z 3.6 z 3.5 z 3.6 z 3.4 z 3.4 z 0.1 < 0.001 
HSI  1.8 zy 2.0 zy 2.2 z 2.1 zy 1.8 zy 1.6 y 1.6 y 0.2 0.009 
LSI 5.1 6.0 5.7 6.0 5.6 5.3 5.1 0.5 0.294 
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Table 3.5. Fatty acid composition of fillet tissue of Florida Pompano fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated 
soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA)h 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA 
Pooled 
SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 7.1 z 4.3 y 4.0 y 3.8 y 4.2 y 3.7 y 3.7 y 0.3 < 0.001 
16:0 28.0 x 32.0 z 30.9 zy 28.9 yx 32.9 z 32.1 z 31.3 z 0.7 < 0.001 
18:0 6.1 x 6.6 yx 6.7 yx 6.2 x 7.3 zy 7.9 z 7.2 zy 0.2 < 0.001 
SFAa 42.4 y 43.8 zy 42.5 y 39.7 x 45.4 z 44.6 zy 43.2 zy 0.7 < 0.001 
16:1 8.5 z 4.3 y 3.8 yx 3.8 yx 3.8 yx 3.3 x 3.4 x 0.2 < 0.001 
18:1n-7 3.0 z 2.4 y 2.1 x 1.9 x 2.3 yx 2.1 yx 2.1 x 0.1 < 0.001 
18:1n-9 12.9 w 27.8 z 24.6 y 21.4 x 24.3 y 21.6 x 19.9 x 0.8 < 0.001 
20:1n-9 0.6 w 1.7 z 1.2 yx 1.1 x 1.4 zy 1.3 yx 1.0 x 0.1 < 0.001 
MUFAb 25.8 w 37.9 z 33.0 y 29.6 x 33.6 y 29.8 x 27.8 xw 0.8 < 0.001 
18:2n-6 9.0 yxw 8.8 xw 9.7 yxw 16.3 z 8.4 w 10.3 yx 10.7 y 0.5 < 0.001 
20:4n-6 0.6 x 0.3 w 0.3 w 0.2 w 0.3 xw 2.7 y 3.0 z 0.1 < 0.001 
n-6c 10.2 x 9.5 x 10.3 x 16.9 z 9.1 x 13.8 y 14.4 y 0.5 < 0.001 
18:3n-3 1.4 y 0.6 y 6.8 z 6.4 z 0.7 y 0.8 y 0.9 y 0.3 < 0.001 
18:4n-3 1.4 z 0.2 y 0.2 y 0.3 y 0.3 y 0.2 y 0.3 y 0.0 < 0.001 
20:4n-3 1.2 z 0.2 y 0.3 y 0.3 y 0.3 y 0.2 y 0.2 y 0.0 < 0.001 
20:5n-3 4.0 z 1.0 x 0.8 x 0.9 x 1.0 x 0.9 x 2.5 y 0.1 < 0.001 
22:5n-3 2.5 z 0.7 x 0.7 x 0.7 x 0.8 x 0.8 x 1.7 y 0.1 < 0.001 
22:6n-3 9.6 z 5.0 y 4.6 y 4.1 y 8.0 z 8.0 z 8.5 z 0.6 < 0.001 
n-3d 20.1 z 7.7 w 13.4 yx 12.7 yx 11.1 yx 11.0 x 14.0 y 0.9 < 0.001 
PUFAe 31.8 z 18.3 v 24.5 xw 30.7 z 21.0 wv 25.5 yx 29.1 zy 1.0 < 0.001 
C18 PUFAf 12.3 x 9.8 wv 16.8 y 23.1 z 9.5 v 11.5 yxw 11.9 xw 0.7 < 0.001 
LC-PUFAg 18.3 z 7.5 x 6.9 x 6.4 x 10.7 y 13.3 y 16.5 z 0.9 < 0.001 
n-3 : n-6 2.0 z 0.8 x 1.3 y 0.8 x 1.3 y 0.8 x 1.0 yx 0.1 < 0.001 
20:3n9 : 20:4n-6 0.000 0.191 0.000 0.000 0.000 0.000 0.000 0.100 0.505 
22:5n-6 : 22:6n-3 0.031 yx 0.045 zyx 0.031 yx 0.031 yx 0.020 x 0.068 z 0.051 zy 0.008 < 0.001 
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Table 3.5, continued.  
a Saturated fatty acids—sum of all fatty acids without double bonds; include 17:0, 20:0, 22:0, 23:0 and 24:0 in addition to individually reported 
SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond; include 14:1, 17:1, 20:1n-9, 22:1n-11 and 22:1n-9 in addition to 
individually reported MUFA 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 16:2n-4, 16:3n-4, 18:3n-6, 18:3n-4, 18:4n-3, 20:2, 20:3n-9, 
20:3n-6, 20:4n-3 and 22:5n-6 in addition to individually reported PUFA 
f C18 PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
h LC-PUFA diet amended with ethyl esters of DHA, ARA, and EPA 
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Table 3.6. Fatty acid composition of liver tissue of Florida Pompano fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated 
soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA)h 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Pooled 
SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 2.4 3.1 3.5 3.0 2.5 2.6 2.4 0.4 0.088 
16:0 36.5 zy 31.0 x 32.2 yx 32.2 yx 38.0 z 36.1 zy 39.1 z 1.4 < 0.001 
18:0 8.4 zy 8.3 zy 8.7 zy 7.8 y 10.6 zy 13.9 z 11.5 zy 1.6 0.020 
SFAa 48.6 zyx 43.1 x 45.0 yx 43.5 x 51.9 zy 54.0 z 54.0 z 2.0 < 0.001 
16:1 2.7 z 2.9 z 2.8 z 2.6 z 1.8 y 1.6 y 1.6 y 0.2 < 0.001 
17:1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.463 
18:1n-7 3.9 z 2.4 y 2.1 yx 2.1 yx 1.6 y 1.6 yx 1.5 x 0.2 < 0.001 
18:1n-9 15.4 x 38.6 z 36.8 z 34.4 zy 26.8 zyx 24.1 yx 23.5 yx 3.7 < 0.001 
20:1n-9 1.4 y 3.4 z 3.2 z 3.1 z 2.4 zy 2.6 zy 2.2 zy 0.4 0.003 
22:1n-9 0.5 y 1.0 z 1.0 z 0.9 zy 0.8 zy 0.9 z 0.7 zy 0.1 0.008 
MUFAb 24.0 w 48.3 z 45.9 zy 43.2 zyx 33.5 yxw 32.2 yxw 29.4 xw 4.1 < 0.001 
18:2n-6 5.0 4.4 4.1 7.6 5.2 2.8 3.6 1.8 0.233 
20:4n-6 1.0 zy 0.1 y 0.1 y 0.2 y 0.3 y 2.6 z 2.8 z 0.7 0.002 
n-6c 6.4 4.7 4.3 7.9 5.5 6.2 7.1 2.2 0.664 
18:3n-3 0.4 zy 0.1 y 1.4 z 1.3 z 0.2 y 0.1 y 0.1 y 0.3 0.001 
20:5n-3 1.5 z 0.1 y 0.1 y 0.1 y 0.2 y 0.1 y 0.5 y 0.2 < 0.001 
22:5n-3 2.2 z 0.1 y 0.1 y 0.1 y 0.3 y 0.2 y 0.6 y 0.2 < 0.001 
22:6n-3 14.5 z 2.9 y 2.3 y 2.3 y 7.4 y 6.5 y 7.3 y 1.8 < 0.001 
n-3d 19.5 z 3.2 y 3.9 y 3.8 y 8.1 y 6.9 y 8.6 y 2.3 < 0.001 
20:2 1.0 zy 0.6 y 0.6 y 1.3 z 0.7 zy 0.5 y 0.7 zy 0.2 0.007 
PUFAe 27.4 z 8.6 y 9.0 y 13.2 zy 14.5 zy 13.8 zy 16.6 zy 4.4 0.015 
C18 PUFAf 5.7 4.5 5.5 8.9 5.4 3.0 3.7 2.0 0.167 
LC-PUFAg 20.4 z 3.3 y 2.7 y 2.8 y 8.2 y 10.2 y 12.0 zy 2.8 < 0.001 
n-3 : n-6 3.0 z 0.7 wv 1.1 xwv 0.5 v 1.5 y 1.2 yxw 1.3 yx 0.1 < 0.001 
20:3n9 : 20:4n-6 NDi NDi NDi NDi NDi NDi NDi NDi NDi 
22:5n-6 : 22:6n-3 0.023 x 0.038 x 0.029 x 0.027 x 0.011 x 0.152 z 0.106 y 0.01 < 0.001 
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Table 3.6, continued.   
a Saturated fatty acids—sum of all fatty acids without double bonds; include 17:0, 20:0, 22:0, 23:0 and 24:0 in addition to individually 
reported SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond; include 14:1 and 22:1n-11 in addition to individually 
reported MUFA 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 16:2n-4, 16:3n-4, 18:4n-3, 18:3n-4, 18:3n-6, 20:3n-6, 
20:3n-9, 20:4n-3, 22:2, 22:5n-6 and 22:5n-3 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double 
bonds ≥ 3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
h LC-PUFA diet amended with ethyl esters of DHA, ARA, and EPA 
i ND – Fatty acid not detected 
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Table 3.7. Fatty acid composition of intraperitoneal fat of Florida Pompano fed diets containing fish oil, hydrogenated soybean oil, or 
hydrogenated soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic 
acid (ARA), or eicosapentaenoic acid (EPA)h 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA 
Pooled 
SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 8.0 z 4.8 y 5.7 zy 4.7 y 5.4 y 4.5 y 5.7 zy 0.7 0.003 
16:0 32.1 y 34.0 zy 36.5 zy 36.1 zy 36.1 zy 36.7 zy 37.6 z 1.5 0.043 
18:0 6.9 y 7.8 y 7.3 y 7.8 y 8.2 zy 10.1 z 9.0 zy 0.7 0.004 
SFAa 48.5 zy 47.8 y 50.7 zy 49.5 zy 51.0 zy 52.6 zy 53.5 z 1.5 0.016 
16:1 8.3 z 4.3 z 4.8 y 4.1 y 4.5 y 3.7 y 4.7 y 0.6 < 0.001 
18:1n-7 3.3 z 2.6 zy 2.5 zy 2.5 y 2.7 zy 2.4 y 2.7 zy 0.2  0.023 
18:1n-9 13.9 y 26.0 z 20.7 z 22.8 zy 21.7 zy 21.7 zy 20.0 zy 2.4 0.008 
20:1n-9 0.8 y 2.0 z 1.3 zy 1.6 zy 1.4 zy 1.6 zy 1.2 zy 0.3 0.051 
22:1n-11 0.9 1.1 1.3 1.0 1.4 0.9 1.4 0.3 0.606 
MUFAb 28.0 y 37.1 z 31.6 zy 32.7 zy 32.7 zy 31.2 zy 30.9 y 1.8 0.008 
18:2n-6 7.6 8.0 7.5 9.3 7.5 6.8 6.5 1.1 0.289 
20:4n-6 0.5 x 0.3 x 0.3 x 0.2 x 0.3 x 1.8 z 1.2 y 0.1 < 0.001 
n-6c 8.6 8.6 8.1 9.7 8.1 9.1 8.1 1.1 0.707 
18:3n-3 1.1 x 0.5 x 3.7 z 2.5 y 0.6 x 0.7 x 0.6 x 0.4 < 0.001 
20:4n-3 1.0 z 0.3 y 0.4 y 0.3 y 0.3 y 0.3 y 0.3 y 0.1 < 0.001 
20:5n-3 2.5 z 0.7 y 0.8 y 0.6 y 0.8 y 0.6 y 1.0 y 0.2 < 0.001 
22:5n-3 2.0 z 0.6 y 0.8 y 0.6 y 0.8 y 0.7 y 1.0 y 0.2 < 0.001 
22:6n-3 5.9 z 3.1 yx 2.9 yx 2.6 x 4.5 zy 4.0 yx 3.6 yx 0.5 < 0.001 
n-3d 13.4 z 5.4 y 8.8 y 6.7 y 7.3 y 6.4 y 6.8 y 1.2 < 0.001 
20:2 0.3 w 0.8 zy 0.6 yxw 1.0 z 0.6 yx 0.6 yxw 0.4 xw 0.1 < 0.001 
PUFAe 23.5 z 15.1 y 17.7 zy 17.8 zy 16.4 zy 16.3 y 15.6 y 2.1 0.021 
C18 PUFAf 10.0 z 8.8 z 11.5 z 12.0 z 8.5 z 7.7 z 7.5 z 1.5 0.039i 
LC-PUFAg 12.3 z 5.3 y 5.3 y 4.4 y 6.9 y 7.8 y 7.4 y 1.0 < 0.001 
n-3:n-6 1.6 z 0.6 x 1.1 y 0.7 x 0.9 zy 0.7 zy 0.8 zy 0.1 < 0.001 
20:3n9 : 20:4n-6 0.119 0.000 0.000 0.000 0.000 0.000 0.000 0.100 0.463 
22:5n-6 : 22:6n-3 0.037 y 0.035 y 0.030 y 0.019 y 0.020 y 0.079 z 0.044 zy 0.011 0.001 
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Table 3.7, continued.   
a Saturated fatty acids—sum of all fatty acids without double bonds; include 17:0, 20:0, 22:0, 23:0 and 24:0 in addition to individually reported 
SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond; include 14:1, 17:1 and 22:1n-9 in addition to individually 
reported MUFA 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 16:2n-4, 16:3n-4, 18:3n-6, 18:3n-4, 18:4n-3, 20:3n-9, 22:2, 
20:3n-6 and 22:5n-6 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 
3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
h LC-PUFA diet amended with ethyl esters of DHA, ARA, and EPA 
i Despite significant findings from the omnibus ANOVA, pairwise comparisons failed to determine significant differences between means 
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Table 3.8. Fatty acid composition of brain tissue of Florida Pompano fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated 
soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA)h 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA 
Pooled 
SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
16:0 25.8 25.1 26.2 26.2 25.5 26.7 25.5 1.4 0.911 
18:0 14.9 14.9 14.2 15.3 15.2 16.1 15.7 0.9 0.501 
24:0 2.2 2.3 2.1 1.9 2.3 2.1 2.4 0.3 0.721 
SFAa 44.9 44.0 44.3 45.0 44.5 46.6 45.4 1.8 0.848 
16:1 2.5 zy 2.4 zy 2.6 z 2.3 zy 2.1 zy 2.1 y 2.1 zy 0.2 0.029 
18:1n-7 1.8 z 1.7 zyx 1.6 yx 1.6 x 1.6 yx 1.7 zyx 1.7 zy 0.0 0.004 
18:1n-9 23.8 26.7 25.9 24.3 25.1 24.1 25.1 1.5 0.448 
MUFAb 28.6 31.6 30.9 28.9 29.4 28.5 29.5 1.6 0.399 
18:2n-6 1.1 w 2.5 y 2.4 yx 3.6 z 1.4 xw 1.5 yxw 1.2 w 0.3 < 0.001 
20:4n-6 1.4 y 1.1 y 1.0 y 1.0 y 1.0 y 3.4 z 3.2 z 0.1 < 0.001 
n-6c 2.8 x 4.4 y 4.0 y 5.4 z 2.7 x 5.5 z 4.9 zy 0.3 < 0.001 
18:3n-3 0.1 y 0.1 y 0.9 z 0.6 z 0.0 y 0.1 y 0.0 y 0.1 < 0.001 
20:5n-3 2.1 z 1.1 x 1.1 x 1.1 x 1.5 y 0.1 w 1.1 x 0.1 < 0.001 
22:5n-3 1.6 z 1.0 yxw 0.9 yxw 0.9 xw 1.1 yx 0.8 w 1.1 y 0.1 < 0.001 
22:6n-3 19.4 17.4 17.3 17.5 20.4 17.4 17.6 1.0 0.051 
n-3d 23.6 z 19.7 yx 20.5 zyx 20.3 zyx 23.1 zy 19.2 x 20.0 zyx 1.1 0.006 
PUFAe 26.5 24.4 24.8 26.1 26.1 24.9 25.1 1.2 0.510 
C18 PUFAf 1.4 w 2.7 yx 3.4 zy 4.4 z 1.5 xw 1.7 xw 1.2 w 0.4 < 0.001 
LC-PUFAg 25.0 21.3 21.1 21.3 24.4 23.1 23.7 1.3 0.584 
n-3 : n-6 8.5 z 4.7 yx 5.2 y 3.8 x 8.7 z 3.5 x 4.1 yx 0.4 < 0.001 
20:3n9 : 20:4n-6 0.000 0.017 0.000 0.000 0.022 0.000 0.014 0.000 0.584 
22:5n-6 : 22:6n-3 0.009 y 0.017 zy 0.009 y 0.013 zy 0.009 y 0.027 z 0.024 z 0.004 0.002 
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Table 3.8, continued.   
a Saturated fatty acids—sum of all fatty acids without double bonds; include 17:0, 20:0, 22:0 and 23:0 in addition to individually reported 
SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond; include 14:1, 17:1, 20:1n-9, 22:1n-11 and 22:1n-9 in 
addition to individually reported MUFA 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 16:2n-4, 16:3n-4, 18:3n-3, 18:3n-6, 18:3n-4, 18:4n-3, 
20:2, 20:3n-9, 20:3n-6, 20:4n-3, 22:2 and22:5n-6 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double 
bonds ≥ 3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
h LC-PUFA diet amended with ethyl esters of DHA, ARA, and EPA 
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Table 3.9. Fatty acid composition of eye tissue of Florida Pompano fed diets containing fish oil, hydrogenated soybean oil, or hydrogenated 
soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (ARA), or 
eicosapentaenoic acid (EPA)h 
 
FISH OIL  
(+) 
CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA 
ARA + 
DHA LC-PUFA 
Pooled 
SE 
P Value 
Fatty acid(s) g/100 g Fatty Acid Methyl Esters (FAME) 
14:0 6.7 z 4.0 y 3.9 y 3.6 y 3.7 y 3.4 y 3.5 y 0.3 < 0.001 
16:0 29.0 y 31.3 z 31.1 z 28.5 y 32.1 z 30.6 zy 30.4 zy 0.6 < 0.001 
18:0 5.8 x 6.9 zy 6.6 yx 6.3 yx 7.5 z 7.6 z 7.0 zy 0.2 < 0.001 
SFAa 42.8 z 43.2 z 42.5 z 39.4 y 44.2 z 42.6 z 41.9 z 0.7 < 0.001 
16:1 7.8 z 3.9 y 3.6 y 3.6 y 3.4 y 3.2 y 3.4 y 0.3 < 0.001 
18:1n-7 3.0 z 2.4 y 2.0 x 2.0 x 2.2 yx 2.2 yx 2.1 yx 0.1 < 0.001 
18:1n-9 14.0 w 26.7 z 23.3 y 20.2 x 23.6 y 20.9 x 19.4 x 0.7 < 0.001 
20:1n-9 0.6 v 1.6 z 1.1 xw 1.0 w 1.4 zy 1.2 yx 1.0 w 0.1 < 0.001 
MUFAb 26.6 w 36.1 z 31.2 yx 28.2 w 32.1 y 29.0 xw 27.1 w 0.7 < 0.001 
18:2n-6 7.5 x 9.7 y 10.3 y 15.7 z 10.2 y 10.9 y 10.1 y 0.4 < 0.001 
20:4n-6 0.7 y 0.3 x 0.3 x 0.3 x 0.3 x 2.9 z 3.1 z 0.1 < 0.001 
n-6c 8.7 w 10.4 x 10.9 x 16.4 z 10.8 x 14.4 y 13.8 y 0.5 < 0.001 
18:3n-3 1.2 x 0.7 x 7.6 z 6.0 y 0.8 x 0.9 x 0.8 x 0.2 < 0.001 
18:4n-3 1.1 z 0.2 y 0.2 y 0.3 y 0.2 y 0.3 y 0.3 y 0.0 < 0.001 
20:4n-3 1.1 z 0.2 y 0.3 y 0.3 y 0.3 y 0.3 y 0.3 y 0.0 < 0.001 
20:5n-3 3.4 z 0.9 x 0.7 x 0.9 x 0.9 x 0.9 x 2.4 y 0.1 < 0.001 
22:6n-3 11.0 z 6.4 y 5.1 y 6.6 y 8.9 z 9.8 z 10.8 z 0.7 < 0.001 
n-3d 20.4 z 9.3 v 14.6 yx 14.9 yx 12.0 w 13.1 xw 16.5 y 0.8 < 0.001 
PUFAe 30.6 zy 20.7 v 26.3 v 32.4 z 23.7 wv 28.4 yx 31.0 zy 0.9 < 0.001 
C18 PUFAf 10.2 w 10.8 xw 18.3 y 22.1 z 11.3 xw 12.1 x 11.3 xw 0.5 < 0.001 
LC-PUFAg 19.2 z 8.9 xw 7.2 w 9.2 xw 11.4 x 15.4 y 19.0 z 0.9 < 0.001 
n-3 : n-6 2.3 z 0.9 x 1.3 y 0.9 x 1.1 yx 0.9 x 1.2 y 0.1 < 0.001 
20:3n-9 : 20:4n-6 NDi NDi NDi NDi NDi NDi NDi NDi NDi 
22:5n-6 : 22:6n-3 0.024 x 0.022 x 0.022 x 0.022 x 0.014 w 0.050 z 0.037 y 0.022 < 0.001 
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Table 3.9, continued.   
a Saturated fatty acids—sum of all fatty acids without double bonds; include 17:0, 20:0, 22:0, 23:0 and 24:0 in addition to individually reported 
SFA 
b Monounsaturated fatty acids—sum of all fatty acids with a single double bond; include 14:1, 17:1, 22:1n-11 and 22:1n-9 in addition to 
individually reported MUFA 
c Sum of all n-6 fatty acids 
d Sum of all n-3 fatty acids 
e Polyunsaturated fatty acids—sum of all fatty acids with ≥ 2 double bonds; include 16:2n-4, 16:3n-4, 18:3n-6, 18:3n-4, 20:2, 20:3n-9, 20:3n-6, 
22:2, 22:5n-6 and 22:5n-3 in addition to individually reported PUFA 
f Sum of all PUFA with chain lengths of 18 carbon atoms PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 
3 
g Long-chain PUFA—sum of all fatty acids with chain length ≥ 20 carbon atoms and double bonds ≥ 3 
h LC-PUFA diet amended with ethyl esters of DHA, ARA, and EPA 
i ND – Fatty acid not detected 
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Table 3.10. Coefficient of distance values for tissues of Florida Pompano fed diets containing fish oil, hydrogenated soybean oil, or 
hydrogenated soybean oil amended with ethyl esters of alpha-linolenic acid (ALA), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic 
acid (ARA), or eicosapentaenoic acid (EPA)1 
 
FISH OIL  
(+) CONTROL 
EFA-Free 
(-) Control ALA C18 PUFA DHA ARA + DHA LC-PUFA 
Fillet 0.0 16.8 15.0 14.2 14.2 12.5 10.7 
Liver 0.0 26.8 25.3 23.5 14.2 13.9 12.3 
Brain 0.0 4.0 3.6 3.5 2.0 3.9 3.2 
Eye 0.0 15.1 14.6 13.7 12.5 10.7 8.9 
Intraperitoneal fat 0.0 13.9 10.2 12.2 10.4 11.8 10.1 
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Figure 1.1: Pathways of long chain PUFA synthesis from n-3, n-6, and n-9 C18 PUFA; Δ5 and Δ6, fatty acid desaturases; Elovl5 and Elovl2, PUFA 
elongases; short, beta-oxidized chain shortening (Tocher 2010)
61 
 
 
Figure 2.1: Generalized experimental design for Nile Tilapia and Florida Pompano trials 
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